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A study of the recognition of tRNACys by E. coli cysteinyl-tRNA 
synthetase using in vivo and in vitro methods was performed. All three 
anticodon nucleotides, the discriminator U73, and some element(s) within the 
tertiary domain (the D stem/loop, the T'PC stem/loop and extra loop) are 
important for recognition; the anticodon stem and acceptor stem appear to 
contain no essential elements. A T7 RNA polymerase transcribed tRNACys is a 
5.5-fold worse substrate than native tRNACys (in terms of the selectivity 
constant, kcat/Km) mainly due to an increase in Km. This may reflect recognition 
of modified nucleotides or subtle effects on the folding of the tRNA. The greatest 
loss of specificity caused by mutation of a single nucleotide occurs when the 
discriminator U73 is changed; kcat/Km declines 3 to 4 orders of magnitude 
depending on the substitution. Mutations in the wobble nucleotide of the 
anticodon also cause reductions in the selectivity constant of 3 orders of 
magnitude, while mutations in the other anticodon nucleotides caused lesser 
effects. Interestingly, a C35A mutation had no effect on aminoacylation by the 
cysteinyl-tRNA synthetase. Several amber suppressor tRNAs were constructed 
whose in vivo identity did not correlate with their in vitro specificity, indicating 
the need for both types of experiments to understand the factor(s) which 
maintain tRNA specificity. Future in vitro experiments will attempt to explain the 
in vivo discrimination between the glycine, phenylalanine, and cysteine tRNAs 
by the cysteinyl-tRNA synthetase. Finally, these results suggest that the notion 
that a small set of isoacceptor specific elements define tRNA identity (the so-
called "second genetic code") is incorrect. A better model is based on 
competition between synthetases for tRNA substrates which contain differing 
amounts of partially overlapping identity determinants. 
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Chapter I 
tRNA discrimination In E. coli 
2 
General Considerations: 
Importance of tRNA recognition: 
The accurate transformation of genes into their physical manifestation as 
the protein products of the cell is critically dependent upon the fidelity of 
translation. To maintain high levels of translational fidelity, aminoacyl-tRNA 
synthetases must accurately discriminate between cognate and non-cognate 
tRNA species. Two characteristics of the system of tRNAs increase the difficulty 
of this task. First, all tRNAs share a similar three-dimensional structure, 
presumably imposed by the requirement that they interact with the ribosome, 
mANA, and elongation or initiation factors. Second, although there are twenty 
aminoacyl-tRNA synthetases in E. coli, one for each normal amino acid, many 
synthetases charge more than one tRNA (Komine et al. , 1990, Sprinzl et al., 
1991 ). These groups of tRNAs which are aminoacylated with the same amino 
acid are known as isoacceptors; the members of an isoaccepting group 
frequently exhibit great sequence or structural variations (Komine et al., 1990, 
Sprinzl et al. , 1991 ). 
tRNA structure: 
The in vivo function of tRNAs dictate that they share a certain degree of 
structural similarity at both the secondary and tertiary levels. Since this 
structural conservation defines one of the problems of tRNA discrimination, and 
dictates the features which are accessible for interactions with synthetases 
some knowledge of tRNA structure is useful. The most common model of tRNA 
structure is yeast tRNAPhe, so this will be the reference for this section. Where 
there is data to suggest variations in other tRNAs, the observed differences will 
be described in the text. 
Figure 1 shows the cloverleaf representation of the secondary structure 
of yeast tRNAPhe. For convenience, the molecule can be divided into several 
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secondary structural domains: the acceptor stem, D stem and loop, anticodon 
stem and loop, variable loop, and T'PC stem and loop. The acceptor stem, site 
of amino acid attachment, contains 7 base pairs and four single stranded 
nucleotides in all but one normal E. coli elongator tRNA. (There are eight base 
pairs and only three single stranded nucleotides in tRNAHis.) Three of the 
single stranded nucleotides, the terminal CCA, are invariant in all tRNAs from all 
species. The amino acid is attached to the terminal adenosine residue on either 
the 2' or 3' hydroxyl group depending on the aminoacyl-tRNA synthetase (for 
review see Moras, 1992). The other single stranded base is nucleotide 73, the 
discriminator (Crothers et al., 1972). The D stem and loop derive their names 
from the one or more dihydrouridine residues present in this loop in all tRNAs. 
The D loop contains two absolutely conserved G residues (G18G19), involved 
in tertiary interactions with the T'PC loop (see below). The number or residues 
in the D loop, and the relative position of the invariant G19G20 sequence varies 
from tRNA to tRNA, as does the size of the stem (between 3 and 4 Watson-Crick 
base pairs depending on the tRNA). The anticodon stem and loop obviously 
derive their name from the presence of the anticodon, nucleotides 34-36. The 
variable loop is as the name suggests; in E. coli tRNAs it ranges in size from 4 
nucleotides up to 21 nucleotides. The size of this loop is often used to classify 
tRNAs; type I tRNAs have short variable loops (4-5 nucleotides) while type II 
tRNAs have long (~13 nucleotides) variable loops. The T'PC stem and loop, 
named for the three invariant residues in the loop are of constant size in all E. 
coli tRNAs, 5 base pairs in the stem, 7 bases in the loop. The secondary 
structure of a tRNA is often described in an abbreviated manner by the number 
of Watson-Crick base pairs in the D-stem and the number of bases in the 
variable loop. Thus a tRNA with 4 base pairs in the D stem and 5 bases in the 
variable loop is of type D4V5. 
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Crystal structures of two uncomplexed tRNAs, yeast tRNAPhe (Kim et al., 
1974) and tRNAAsp (Westhof et al. , 1985) have been solved, providing models 
of tertiary structure for D4V5 (Phe) and D3V4 (Asp) tRNAs. These structures are 
thought to be representative of most type I tRNAs since many of the interactions 
which produce the tertiary structure involve invariant nucleotides. The crystal 
structure of both tRNAs shows an "L" shaped molecule with extensive tertiary 
interactions between the secondary structural elements. Figure 2A shows the 
tertiary structure of tRNAPhe with the various secondary structural domains 
labeled. The tertiary interactions which produce the structure in Figure 2A are 
shown on a cloverleaf representation of tRNAPhe in Figure 28. The structure 
shows extensive contacts between the D stem and loop and the variable and 
T'PC loops. Several of the tertiary interactions deserve special mention. The 
base pair between U8 and A 14 is usually called the reverse-Hoogsteen base 
pair. The base pair between G15 in the D loop and C48 in the variable loop is 
called the Levitt pair (Levitt, 1969). All E coli tRNAs with the exception of 
tRNACys (which is G15:G48) have a G15:C48 or an A15:U48 Levitt pair 
(Komine et al., 1990, Sprinzl et al., 1991 ). Nucleotides 26 and 44 are frequently 
referred to as the "propeller twist" nucleotides, because their base pairing 
interaction is not planar, but twisted like the blades of a propeller. The tertiary 
structure of the tRNA produces a feature known as the variable pocket (Ladner, 
1975), a group of 5 single stranded nucleotides which are placed in close 
proximity in an accessible depression near the bend of the "L". The variable 
pocket nucleotides are 16, 17, 20, 59, and 60; the location of these nucleotides 
is indicated on both Figure 2A and 28. 
The crystal structure of tRNAAsp (Westhof et al., 1985) also shows an "L" 
shaped molecule, but there are some minor differences in the tertiary structure. 
There is no tertiary interaction between the invariant G19 and C56, as seen in 
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tRNAPhe. Also the nature of the interaction between nucleotide 21 and the 
reverse-Hoogsteen base pair (US:A 14) is slightly different. In yeast tRNAPhe 
nucleotide 21 is only hydrogen bonding to the phosphate backbone of US, 
whereas in tRNAAsp the base appears to hydrogen bond with both the 
phosphate backbone of US and the base of nucleotide 14. In addition, there is 
functional evidence involving aminoacylation by the yeast aspartyl- and 
phenylalanyl-tRNA synthetases which support the theory that the conformation 
of tRNAAsp is subtly different than of yeast tRNAPhe.(see Giege et al., 1990, 
Perret et al., 1992) 
Recognition and Identity: 
Discrimination by aminoacyl-tRNA synthetases between structurally 
similar cognate and non-cognate tRNAs involves two elements, recognition and 
identity (for review see Schulman, 1991 ). Recognition is the term applied to the 
interaction between a tRNA and its cognate synthetase, and the elements on a 
tRNA which are required for this interaction are called recognition elements. 
Recognition elements can be specific nucleotides which are recognized by a 
synthetase, or structural features which correctly orient other elements which 
are directly recognized by the synthetase. All recognition elements are by 
definition positive elements, that is, the presence of the element aids in the 
creation of a productive interaction between tRNA and synthetase. Removal of a 
recognition element therefore causes a reduction in the catalytic efficiency of 
aminoacylation by the cognate synthetase. Identity is the term used to describe 
the amino-acid-acceptance of a tRNA in vivo, and the sequence and structural 
elements which are required to confer a specific amino-acid-acceptance are 
called identity elements. Unlike recognition elements, identity elements can act 
in either a positive or a negative fashion. A positive identity element is a 
recognition element, that is, the presence of the element aids in the formation of 
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a productive interaction with the cognate synthetase. Negative elements on the 
other hand, work by preventing productive interactions with non-cognate 
synthetases. From a phenotypic standpoint, removal of either type of identity 
element should have the same effect, a loss of in vivo identity. 
In vivo versus In vitro experiments: 
There are two obvious ways to study the interaction of tRNA and 
aminoacyl-tRNA synthetase; both involve changing the sequence and/or 
structure of tRNAs and seeing what effect the mutations have on aminoacylation 
of the tRNA. The difference comes from the way that the effects are determined; 
either a tRNA may be put into a cell, and its amino-acid-acceptance determined, 
or the tRNA may aminoacylated in vitro and the kinetic constants for the new 
tRNA compared against those of a wild-type tRNA. The different environments in 
which the two types of experiments occur define the aspects of the 
tRNA:synthetase interaction which each type of experiment can study. Since in 
vitro experiments generally involve one, or at most two aminoacyl-tRNA 
synthetases, they study tRNA recognition, not tRNA identity. In vivo experiments 
on the other hand take place in a milieu where all twenty aminoacyl-tRNA 
synthetases are present, hence they study tRNA identity rather than recognition. 
Ultimately, both types of experiments are required to understand discrimination, 
since (as indicated above) the in vivo effect of removing an identity element is 
the same regardless of whether the element is positive or negative. A distinction 
can be made in vitro between a positive and a negative identity element 
because removal of a purely negative element will have little effect on 
aminoacylation with the cognate synthetase, but only an in vivo experiment 
could suggest that the negative element was there in the first place. 
Practical considerations also dictate what can and cannot be studied by 
the two types of experiments. The experimental details of in vitro studies are 
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fairly straightforward; mutant tRNAs are prepared and then aminoacylated at 
different RNA concentrations to estimate the value of the coefficients of the 
Michaelis-Menten equation (kcat and Km ). The only variations involve the 
source of the RNA and the way that the mutants are generated. Initially, tRNAs 
had to be isolated in vivo and then mutated by chemical or enzymatic means, 
but this was later supplanted by preparing RNA from cloned tRNA genes with 
mutations introduced at the DNA level. A simpler way to isolate tRNAs was 
pioneered by Sampson and Uhlenbeck (1988) who used T7 RNA polymerase 
to produce an unmodified yeast tRNAPhe which was aminoacylated with nearty 
the same kinetics as the native tRNA. This method has the advantage that it can 
be used to rapidly prepare and test the effects of any mutation at any position in 
the tRNA; the limitation of this method, of course, is that it cannot study the 
effects of modified nucleotides, which have been shown to be important for 
recognition by several aminoacyl-tRNA synthetases including the isoleucyi-
(Muramatsu et al., 1988) and lysyl- (Tamura et al., 1992) tRNA synthetases. 
To understand the practical strengths and limitations of in vivo studies, it 
is important to understand the methods used in such experiments. Most in vivo 
studies attempt to determine the identity elements for an isoaccepting group by 
performing an identity swap; that is, mutations are made in a noncognate tRNA 
until it is converted into a cognate tRNA. This approach was first used by 
Normanly et al. (1986a) who converted a leucine accepting tRNA into a serine 
accepting tRNA. The most common type of in vivo study uses an amber or opal 
suppressor tRNA as the experimental substrate. The in vivo identity of the tRNA 
can then be determined by studying the effect of the suppressor tRNA on a 
reporter gene with a nonsense mutation, either by testing for an amino acid 
specific phenotype or by directly sequencing the protein product. The limitation 
of this method, of course is that the anticodon must be either CUA or UCA, due 
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to the requirement that the tRNA be a nonsense suppressor. Since many 
aminoacyl-tRNA synthetases use the anticodon as recognition and/or identity 
elements, this is a serious problem (see below and Schulman, 1991 ). In 
addition, the amber anticodon contains residues which are important for the 
recognition of the lysyl-tRNA synthetase (U35, Tamura et al., 1992) and 
glutaminyl-tRNA synthetase (C34 and U35, Jahn et al., 1991 ). Thus identity 
elements for these two tRNAs are introduced into all identity swap experiments 
which use amber suppressor tRNAs. A new method (Chattapadhyay et al., 
1990) allows the role of the anticodon to be investigated by incorporating the 
anticodon of interest into an E. coli initiator tRNA (tRNAfmet), and then 
sequencing protein produced from a reporter gene in which the corresponding 
codon replaces the normal AUG initiation sequence. Although useful, this 
method has weaknesses also, principally that the only tRNA body which can be 
used is that of tRNAfmet. 
Competition as the driving force behind identity: 
In vivo, there are two factors which define the identity of a tRNA; the total 
catalytic efficiency of the reaction with the cognate synthetase, and the sum of 
the catalytic efficiencies with the other twenty synthetases. To retain a specific in 
vivo identity, a tRNA must contain enough positive and negative identity 
elements so that the cognate synthetase can successfully compete against all 
other synthetases for the substrate. If the competitive model is true then altering 
the factors which influence the total catalytic efficiency of aminoacylation 
(namely kcat and Km) should affect identity. Modeling studies using tRNAs with 
dual identities suggest that the primary factor which would affect discrimination 
in vivo is kcat (Hou and Schimmel, 1989a). While kcat is fixed its manifestation 
Vmax can be changed by increasing synthetase concentration. Thus, if 
competition is important to recognition, changing the balance between the 
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concentrations of the tRNA and the synthetase should affect the fidelity of 
aminoacylation and the identity of certain tRNAs. 
Several workers have dramatically demonstrated the principle that the 
balance between synthetase and tRNA can in fact, affect identity. Swanson et 
al. (1988) observed that in the presence of excess glutaminyl-tRNA synthetase 
an amber suppressor tRNA which was normally aminoacylated with tyrosine 
was also aminoacylated with glutamine. Increasing the concentration of 
tRNAGin2 could compensate for the effect of the increased levels of synthetase 
because the cognate tRNAGin2 could out compete the amber suppressor for 
the glutaminyl-tRNA synthetase. The complementary effect was observed by 
Hou and Schimmel (1989a). They reported that a mutant amber suppressor 
tRNATyr which contained recognition elements for the alanyl-tRNA synthetase, 
was aminoacylated with tyrosine (and about 5% glutamine) but no alanine in 
vivo. However, the addition of a plasmid which overexpressed the alanyl-tRNA 
synthetase caused the tRNA's identity to change so that it was aminoacylated 
with a mixture of tyrosine and alanine. Recently Sherman et al. (1992) was able 
to directly demonstrate both in vivo and in vitro that competition can affect 
identity. The supF amber suppressor tRNA (derived from tRNATYr) is 
aminoacylated in vivo with both tyrosine and glutamine. Aminoacylation by the 
glutaminyl-tRNA synthetase is prevented when the competing tyrosyl-tRNA 
synthetase is overproduced in the cell . Similarly, in an in vitro aminoacylation 
assay the fraction of supF tRNA aminoacylated with glutamine was reduced 
60% when tyrosyl-tRNA synthetase was added. This effect is not specific to this 
tRNA, the addition of glutamate-tRNA synthetase reduced the amount of 
misacylation of tRNAGiu with glutamine in proportion to the amount of GluRS 
added. 
Features used by synthetases to identify tRNAs: 
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General: 
The tRNA sequence elements which are used to distinguish different 
isoacceptors vary from group to group. Nevertheless, these elements tend to fall 
in only five major regions of the tRNA. These regions are the anticodon, the 
acceptor stem (excluding the discriminator), the discriminator, the variable 
pocket, and the extra loop (in type II tRNAs). Although this may appear on the 
surface to be a fairly random grouping, these elements constitute the most 
accessible elements on the tRNA. The anticodon, discriminator, variable pocket 
and many extra loop nucleotides are single stranded and present no physical 
impediments to interactions (i.e., they are not blocked by other residues), while 
the acceptor stem and the remaining variable loop nucleotides are helical RNA, 
whose minor groove is accessible by proteins. The next section details which 
synthetases use elements in these regions as part of their recognition or identity 
sets. 
Anticodon: 
The obvious solution to identifying tRNAs is for the synthetase to contact 
and "read" the anticodon. While logical from an informational perspective, there 
were two problems from a mechanistic standpoint. First is the problem of 
isoacceptors; namely how can a protein recognize several different nucleotides 
at one position while excluding non-cognate tRNAs which also have one or 
more anticodon nucleotides in common? This is a particular problem for the 
seryl-tRNA synthetase, which has no absolutely conserved anticodon 
nucleotides (Komine et al., 1990, Sprinzl et al., 1991 ). The second problem is 
the question of distance; how can a protein transfer the identity information 
gained at the anticodon to the active site at the end of the acceptor stem? 
Although allosteric enzymes were available as models for enzymes which can 
change substrate Km's by interaction at a second, distal site, there were no 
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models in which the modulation of activity was at the level of kcat (at least until 
the cocrystal structure of E. coli tRNAGin:glutaminyHRNA synthetase was 
solved, Rould et al., 1989). 
There was however, growing evidence (see for example, Saneyoshi and 
Nishimura, 1971 , Squires and Carbon, 1971, and Kern and LaPointe, 1979) 
that the anticodon was involved in tRNA recognition and identity. Schulman and 
Pelka (1983) are credited with the first definitive proof that the anticodon is 
recognized in vitro by aminoacyl-tRNA synthetases. They showed that the 
anticodon was important for recognition of the E. coli initiator tRNAfmet by the 
methionyl-tRNA synthetase by demonstrating that substitutions of the anticodon 
nucleotides reduced the rate of aminoacylation in vitro. Direct proof of the 
importance of the anticodon in identity was somewhat slower in coming, 
although the misacylation with glutamine and lysine of several amber 
suppressor tRNAs (anticodons switched to CUA) suggested that the anticodon 
was important for identity in some cases (Normanly et al. , 1990). Although 
comparison of the effects of amber and opal suppressor mutants proved the 
importance of some anticodon residues in some systems in vivo (for instance 
McClain et al. , 1990), direct testing of the effects of anticodon nucleotides was 
not available until the development of the E. coli initiation test system 
(Chattapadhyay et al., 1990, and above). 
Application of in vivo and in vitro methods have shown that the anticodon 
is involved in discrimination in 17 isoaccepting groups in E. coli (see Table 1). 
Only three E. coli aminoacyl-tRNA synthetases completely ignore all three 
anticodon nucleotides, those for alanine, leucine, and serine. Two of these 
synthetases (the leucine and serine enzymes) recognize type II tRNAs with the 
distinctive long variable loop. 
Acceptor stem (excluding discriminator): 
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The theoretical problems associated with anticodon recognition 
(especially the distance problem) are not associated with acceptor stem 
recognition since this region is in close proximity to the site of the 
aminoacylation reaction. Recognition in the acceptor stem has proven very 
amenable to study by both in vivo and in vitro methods using normal tRNAs, 
amber and opal suppressor tRNAs, and model substrates such as minihelices 
(a stem loop structure composed of the acceptor stem connected to the T'PC 
stem and loop), microhelices (the acceptor stem closed by an RNA loop), and 
linear RNA duplexes with as few as 4 base pairs (Schulman, 1991, Musier-
Forsyth et al., 1991 a). Historically, the initial demonstration that acceptor stem 
elements were important in identity was performed by Normanly et al. (1986a) 
who found that serine acceptor stem nucleotides were required to switch a 
leucine accepting tRNA into a serine accepting tRNA. The first evidence of 
acceptor stem recognition was from Hou and Schimmel (1988) who 
demonstrated that a G3:U70 base pair was the prime determinant of alanine 
acceptor activity. 
Acceptor stem discrimination (excluding the discriminator nucleotide 73) 
has been shown to be important in eight isoaccepting groups (Table II). In at 
least one isoaccepting group (alanine) acceptor stem recognition is the 
dominant component in both the recognition and identity processes (see 
references in Table II). To date only two aminoacyl-tRNA synthetases have 
been shown to ignore the acceptor stem (excluding the discriminator) in 
recognition: the phenylalanyl- and cysteinyl-enzymes (Table II). 
Discriminator: 
The discriminator was originally proposed as an important 
identity/recognition element by Crothers et al. (1972) based on the limited 
number of tRNA sequences then available. Although not a universal recognition 
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element the discriminator has been shown to be important in recognition and/or 
identity in 18 isoaccepting groups (Table Ill). Only the serine and threonine 
enzymes have been shown to not utilize the discriminator in either recognition 
and/or identity. There are currently two models for discriminator action ; one is 
direct recognition of the single stranded nucleotide by the synthetase. The other 
(based on evidence from the tRNAGintglutaminyl-tRNA synthetase cocrystal 
structure) is that the discriminator helps position the CCA terminus in the active 
site by intramolecular hydrogen bonding with the acceptor stem (Rould et al., 
1989, Perona et al., 1989). 
Variable pocket: 
The variable pocket, first proposed as a defined region by Ladner et al. 
(1975), has also been shown to be involved in tRNA discrimination both in vivo 
and in vitro. The variable pocket is composed of single stranded nucleotides 16, 
17, 20, 59 and 60 (numbering of Sprinzl et al. , 1991 ), which are placed in close 
proximity in a depression near the bend in the "L" structure of the molecule (see 
above). Since all 5 nucleotides are single stranded, they would be particularly 
amenable to making sequence specific contacts with synthetases. The 
paradigm for variable pocket recognition is the yeast phenylalanyl-tRNA 
synthetase, which requires G20 for efficient aminoacylation (Sampson and 
Uhlenbeck, 1988, Sampson et al., 1989, Sampson et al. , 1992). To date, five E. 
coli isoaccepting groups have been shown to utilize variable pocket elements 
as part of their identity and/or recognition mechanisms (Table IV). 
Unusual elements: 
lsoaccepting groups which are known to depend on other types of 
elements to define their identity are shown in Table V. These elements fall into 
the general categories of modified or nonstandard nucleotides, central core 
nucleotides (which includes the D-stem), and large variable loops. As seen in 
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Table V, there are two known cases of modified residues being involved in 
tRNA recognition : lysidine34 in tRNAIIe and mnm5s2U34 found in tRNALYS. The 
nonstandard G at the -1 position in tRNAHis is known to be important for 
recognition by the histidyl-tRNA synthetase. Central core nucleotides are known 
to be important in recognition or identity by the phenylalanyl-, glutaminyl-, and 
seryl-tRNA synthetases. Finally, the large variable loops found in type II tRNAs 
are important for recognition and/or identity of the seryl- and tyrosyl-tRNA 
synthetases. 
Integrating data from different sources: 
Introduction: 
Studying the experiments whose data are summarized in the tables it 
can be seen that the correspondence between the in vitro and in vivo columns 
is not always 100%. As indicated earlier, identity and recognition are not the 
same process. For this reason it is instructive to compare the results of identity 
and recognition studies. It is also instructive to compare the results of 
recognition and identity experiments with structural studies from cocrystals of 
tRNAs and aminoacyl-tRNA synthetases. Thus, the remainder of this chapter will 
focus on comparisons of data obtained from different types of experiments. 
Specifically, the relationship between the recognition and identity sets in two 
well studied E. coli isoaccepting groups, alanine and phenylalanine, will be 
investigated, and the results of the only tRNA:aminoacyl-tRNA synthetase 
cocrystal structure (glutamine) will be compared to discrimination data obtained 
from molecular genetic experiments. 
Alanine: 
The primary determinant of alanine recogntion and identity in E. coli (and 
many other organisms as well} is a single base pair G3:U70 in the acceptor 
stem (Figure 3, Hou and Schimmel, 1988, Hou and Schimmel, 1989b, Shi et al., 
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1990). Several theories have been advanced to explain the importance of the 
wobble (G:U) pair (see for instance, McClain et al., 1988c) but a study with 
nucleotide analogs has conclusively demonstrated that the function of the G:U 
is to leave the exocyclic amine of G3 unpaired in the acceptor stem (Musier-
Forsyth et al., 1991 b). 
Several other nucleotides (Figure 3) contribute to alanine recognition in 
vitro, these include the discriminator A73 (Shi et al., 1990, Shi and Schimmel, 
1991, Tamura et al., 1991 b), base pair G2:C71 (Francklyn et al., 1992) and G20, 
a variable pocket nucleotide in the D-loop (Tamura et al., 1991 b). All of these 
elements are less important than the wobble pair at 3:70; that is changing these 
elements causes less dramatic effects than those caused by mutations in the 
wobble pair. 
The identity set of tRNAAia matches the recognition set fairly well. The 
G3:U70 base pair is a major determinant of alanine identity; transfer of this 
element into amber suppressors of tRNALys (McClain et al., 1988c), tRNAPhe 
or tRNACys (Hou and Schimmel, 1988) is sufficient to switch the identity of the 
tRNA to Ala (in Lys and Cys backgrounds) or at least add some alanine identity 
(in a Phe background). The discriminator has also been shown to be an identity 
element (McClain et al., 1991 b), as was base pair 2:71 and the unpaired G20 
(McClain et al., 1988c). Only two elements were found to be part of the identity 
set which were not previously defined as recognition elements, base pair 1 :72 
(McClain et al., 1991 b), and C60 (McClain et al., 1988a) a variable pocket 
nucleotide in the "f\PC loop. The effect of G1 :C72 on aminoacylation with 
alanine is unknown, but C60 mutations have only minor effects (Tamura et al., 
1991 b), suggesting that C60 is a negative identity element. The fact that a C60U 
mutation in tRNAAia causes some lysine to appear in an amber suppressor 
tRNA tends to support this view. 
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Phenylalanine: 
The definitive study of recognition by the E. coli phenylalanyl-tRNA 
synthetase (FRS) is by Peterson and Uhlenbeck (1992); all recognition data 
reported herein are derived from this study (see Figure 4). They found that the 
important recognition elements for FRS found in E. coli tRNAPhe are the 
anticodon, U20 and U59 in the variable pocket, the propeller twist nucleotides, 
and three residues (1 0,25, and 45) which form a tertiary interaction in the 
central core of the molecule. Peterson and Uhlenbeck also list the discriminator 
as a recognition element, although mutations at this site cause reductions in 
kcat/Km of only 1.6- to 2-fold in an E. coli tRNAPhe background. In a yeast 
tRNAPhe background 6-fold effects are observed when the discriminator is 
mutated, hence the element was included in the recognition set. 
The identity set for E. coli tRNAPhe was investigated by McClain and 
Foss (1988) in amber suppressors and by Chattapadhyay et al. (1990) using an 
initiation system. The identity set is composed of at least 11 nucleotides: A36 in 
the anticodon (Chattapadhyay et al., 1990) U20, U59, and U60 (and possibly 
U16 and U17) in the variable pocket, G27:C43 and G28:C42 in the anticodon 
stem, G44 and U45 in the variable loop, and the discriminator A73 (McClain 
and Foss, 1988). The effects on phenylalanine identity of the other two 
anticodon nucleotides, the D stem, 16 and 17 in the D loop, G1 :C72, A26 in the 
propeller twist, and the remaining 3 nucleotides of the variable loop have not 
been examined. 
Several correlations appear immediately. Anticodon nucleotide A36 is 
both an identity element and a recognition element, as are nucleotides U20 and 
U59 in the variable pocket, G44 and U45 in the variable loop, and the 
discriminator U73. Equally apparent is the fact that U16, U17, and U60 in the 
variable pocket, and G27:C43 and G28:C42 in the anticodon stem which 
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appeared to be important for identity are not important in the recognition 
process. Similarly, nucleotides 34 and 35 which seemed to be unimportant for 
identity were in fact quite important for recognition. No correlations between the 
in vivo and in vitro behavior of the remaining recognition nucleotides (1 0, 25, 
and 26) can be ascertained because they have not been tested in both systems. 
Although at first approximation a jumble, this data can be adequately 
integrated. The elements contained in both the identity and recognition sets are 
obviously positive identity elements, while the nucleotides which are found to 
be important for identity but not important for recognition (U16, C17, U60 in the 
variable loop and G27:C43 and G28:C42 in the D stem) are negative identity 
elements, whose sole function is to prevent productive interactions with non-
cognate synthetases. Since the variable pocket nucleotides are used as 
recognition elements by many aminoacyl-tRNA synthetases (see above and 
Schulman, 1991) U16, C17 and UGO are logical negative elements. The 
anticodon stem elements are less understandable, since no known aminoacyl-
tRNA synthetase uses the anticodon stem as a recognition element. However 
C34 and U35 in the amber anticodon are known to be recognition elements for 
the glutaminyl-tRNA synthetase (Jahn et al., 1991 ). Perhaps these base pairs 
can change the orientation of the anticodon with regard to their binding pocket 
on the glutaminyl-tRNA synthetase. There is circumstantial evidence to support 
this theory; Komatsoulis and Abelson (1993) found that changes in the 
anticodon stem can affect the level of glutamine identity of amber suppressor 
tRNAs in vivo. To integrate the rest of the data it is necessary to presuppose that 
tRNAPhe is overspecified. If tRNAPhe is overspecified then the loss of one or 
two recognition elements (i.e., G34 and A35) may not affect identity significantly. 
The fact that at least five isoaccepting groups which recognize anticodon 
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elements retain in vivo identity as amber suppressors suggests that this is not 
an unreasonable postulate. 
Glutamine: 
A cocrystal structure of the glutaminyl-tRNA synthetase and tRNAGin has 
been solved to 2.5A resolution (Rould et al., 1989, Perona et al., 1989, Rould et 
al., 1991 ), and concurrent studies conducted of the recognition of the tRNA by 
the synthetase (Jahn et al., 1991, Hayase et al. , 1992). The result of this work is 
a detailed, coherent view of the interaction of a tRNA and an aminoacyl-tRNA 
synthetase. 
Figure 5 shows the nucleotides which have been shown to be involved in 
specific interactions with the synthetase. Unsurprisingly, the synthetase makes 
extensive stacking and hydrogen bonding contacts with the CCA terminus, 
particularly C74 and A76, the site of amino acid attachment. Specific contacts 
are seen between the synthetase and the exocyclic amines of G2 and G3 
(which are found in the minor groove of the acceptor helix) partially mediated by 
a water molecule. Specific contacts are also seen between the exocyclic amine 
of G10 and the synthetase, and between C16 and Gln13 of the synthetase. All 
three anticodon nucleotides in the anticodon (34-36) and two nucleotides in the 
anticodon loop (37 and 38) are also recognized by the synthetase in a 
sequence specific manner. Although not recognized directly U32 and U33 are 
required to base pair with nucleotides 37 and 38 for proper interaction of the 
anticodon with the synthetase. Base pair 1 :72 and nucleotide 73 are also not 
involved in nucleotide specific contacts with the synthetase, but the cocrystal 
indicates that they form structures which are important for the tRNA to adopt the 
proper configuration for aminoacylation. The first base pair is melted by the 
enzyme; thus the interaction is specific for a base pair which is disrupted easily. 
The exocyclic amine of the discriminator, G73, forms an intramolecular 
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hydrogen bond with the phosphate of residue A72 (which is not base paired 
after interaction with the synthetase), to maintain a hairpin turn that positions the 
CCA terminus in the active site. 
All of these residues have been studied for their effects on in vitro 
aminoacylation with purified glutaminyl-tRNA synthetase (Jahn et al., 1991, 
Hayase et al., 1992). The conclusions which can be drawn from this data is that 
mutations in all but one of the contact residues tested (G2, G3, G1 0, C34, U35, 
G36, A37, and U38) cause reductions in the total catalytic efficiency of the 
aminoacylation reaction. The only exception to this was C16; a C16U mutation 
caused only a 2-fold reduction in total catalytic efficiency of aminoacylation. 
Furthermore, mutations which affect the helix at the G2 or G3 base pair (i.e., by 
introducing a helical irregularity with a G:U wobble pair) also cause reductions 
in the total catalytic efficiency. The cocrystal data indicated that the interactions 
with G2, G3 and G1 0 were mediated through the exocyclic amino group of the 
guanosines. This was directly tested by making mutant tRNAs in which inosine 
residues individually replaced each of the G residues. Since inosine lacks the 
minor groove exocyclic amine, these replacements would be expected to affect 
kcat/Km, and in fact this is what is observed. Mutations at the discriminator 
position (which helps hold the CCA terminus in place) also cause reductions in 
the catalytic efficiency of aminoacylation. The cocrystal structure indicates that 
the only important characteristic of the U1 :A72 base pair is that it is easily 
denatured, and experiments bear this out. A G1 :A72 mismatch has the same 
catalytic efficiency as wild-type U1 :A72 tRNAGin, although the wild-type tRNA 
has a Km approximately four times lower than the G1 :A72 mutant. Furthermore, 
a tRNA with a deletion of nucleotide 1 (i.e., the transcript starts at G2) is only a 2-
fold worse substrate in terms of the selectivity constant than the U1 :A72 wild-
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type tRNA (although Km is increased 6-fold in the deletion mutant). In summary, 
there is excellent fit between the results of genetic and physical studies. 
Concluding remarks: 
There is a great deal of order emerging from the chaos which until 
recently described the results of studies on tRNA recognition and identity. What 
had previously seemed to be a set of idiosyncratic rules governing the 
interaction between synthetases are becoming clearer as more study indicates 
that tRNA:synthetase interactions generally occur in five well defined regions of 
the tRNA: the anticodon, the acceptor stem, the discriminator, the variable 
pocket, and the extra arm (in type II tRNAs). Additionally, a new paradigm for in 
vivo identity has developed out of the relatively recent understanding of the 
importance of competition between synthetases in maintaining fidelity (see Soli, 
1990). The new paradigm states that identity is determined by competition 
among synthetases for substrate molecules which contain different numbers of 
partially overlapping identity elements. No doubt, as work in this field continues, 
the gaps in Tables 1 to 4 will be filled, and our understanding of tRNA 
discrimination will be more complete. 
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Table I 
Anticodon discrimination by E. col/ aminoacyl-tRNA synthetases 
Synthetase 
Alanyl-
in vitro in vivo References: 






















































1988, Tamura et al., 1991 b 
Pallanck et al., 1992, Shimizu et al., 1992, 
Komatsoulis & Abelson, 1993 
Normanly et al., 1990, Shimizu et al., 1992 
Saneyoshi & Nishimura, 1971, Kern & 
LaPointe, 1979, Normanly et al., 1990 
Peterson & Uhlenbeck, 1992, 
Chattapadhyay et al. , 1990, Pallanck & 
Schulman, 1991 
Squires & Carbon, 1971, McClain et al., 
1991a 
Shimizu et al., 1992 
Maramatsu et al., 1988, Pallanck & 
Schulman, 1990 
McClain et al., 1990, Normanly et al., 1990, 
Tamura et al., 1992 
Shimizu et al., 1992 
Schulman & Pelka, 1983, Schulman & 
Pelka, 1985, Schulman & Pelka, 1988, 
Schulman & Pelka, 1990, Chattapadhyay et 
al., 1990, Pallanck & Schulman, 1991 
Shimizu et al., 1992 
Shimizu et al., 1992 
Schulman & Pelka, 1985, Jahn et al., 1991, 
Rould et al. , 1989, Rould et al., 1991, 
Normanly et al., 1990. · 
Schulman & Pelka, 1989, McClain et al. , 
1990, Tamura et al., 1992 
J. Sampson & M. Saks, pers. comm., 
Himeno et al., 1990 
Schulman & Pelka, 1990 
Schulman & Pelka, 1988, Pallanck & 
Schulman, 1991, Tamura et al., 1991 a 
Himeno et al., 1991, Pak et al., 1992, 
Rogers et al., 1992 
Hou & Schimmel, 1989a, Himeno et al., 
1990, 
*Amber suppressor retains its in vivo identity-data taken from Normanly et al. , 
1990, except for Leu & Ser (Normanly et al., 1986a) and Cys & Phe (Normanly 
et al., 1986b) 
tNo functional amber suppressor tRNAAsn has ever been produced. 
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Table II 
Acceptor stem discrimination by E. coli amlnoacyl-tRNA 
synthetases (does not Include discriminator nucleotide) 
Synthetase in vitro in vivo References 
Alanyl- Yes Yes Hou & Schimmel, 1988, McClain & Foss, 
1988a, McClain et al., 1988c, Park & 
Schimmel, 1988, Francklyn & Schimmel, 
1989, Hou & Schimmel, 1989a, Hou & 
Schimmel, 1989b, Shi et al., 1990, Musier-
Forsyth et al., 1991 b, Tamura et al., 1991 b, 
Cysteinyl- No 
Francklyn et al., 1992 
? Komatsoulis & Abelson, 1993 
Aspartic- ? ? 
Glutamic- ? ? 
Phenylalanyl- No No McClain & Foss, 1988d, Peterson & 
Uhlenbeck, 1992 
Glycyl- Yes Yes McClain & Foss, 1991, Francklyn et al., 
1992 
Histidyl- Yes ? Francklyn & Schimmel, 1989, Himeno et al., 
1989, Francklyn et al., 1992 (see Table V) 
lsoleucyl- ? ? 
Lysyl- ? ? 
Leucyl- ? ? 
Methionyl- ? ? 
Asparaginyl- ? ? 
Prolyl- ? ? 
Glutaminyl Yes Yes Rogers & Soli, 1988, Perona et al., 1989, 
Rould et al., 1989, Jahn et al., 1991, Rould 
et al., 1991, Hayase et al., 1992 
Arginyl- ? ? 
Seryl- ? Yes Normanly et al., 1986a, Normanly et al., 
1992 
Threonyl- ? ? 
Valyl- Yes ? Tamura et al., 1991a 
Tryptophanyl- Yes No* Himeno et al., 1991, 
Tyrosyl- ? ? 
* Mutations of base pairs 1 :72, 2:71, and 3:70 in an opal suppressor retained 
Trp identity, but suppression efficiency was reduced. 
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Table Ill 
Discriminator recognition and Identity in E. coli aminoacyl-tRNA 
synthetases 
Synthetase in vitro in vivo References 
Alanyl- Yes Yes Hou & Schimmel, 1988, McClain et al., 
1991 b, Shi et al., 1990, Tamura et al., 
1991 b, Shi & Schimmel, 1991, 
Cysteinyl- Yes ? Komatsoulis & Abelson, 1993, Pallanck et 
al., 1992 
Aspartic- Yes ? Hasegawa et al.. 1989 
Glutamic- Yes ? Shimizu et al., 1992 
Phenylalanyl- No; Yes Peterson & Uhlenbeck, 1992, Pallanck, Li, 
& Schulman, pers. comm. 
Glycyl- Yes Yes McClain et al., 1991 a, Francklyn et al., 1992 
Histidyl- Yes ? Himeno et al., 1989, Francklyn & Schimmel, 
1990, Francklyn et al.. 1992 
lsoleucyl- Yes Yes Shimizu et al., 1992, Pallanck, Li, & 
Schulman, pers. comm. 
Lysyl- Yes Yes McClain et al., 1990, Tamura et al., 1992 
Leucyl- Yes Yes Asahara et al., 1993, Normanly et al., 1992 
Methionyl- Yes ? Shimizu et al., 1992 
Asparaginyl- Yes ? Shimizu et al., 1992 
Prolyl- Yes ? Shimizu et al., 1992 
Glutaminyl Yes ? Perona et al.. 1989, Rould et al., 1989, Jahn 
et al., 1991, Rould et al., 1991, 
Arginyl- Yes Yes§ Tamura et al., 1992, McClain et al., 1990 
Seryl- No Yes Himeno et al., 1990, Normanly et al., 1992, 
Shimizu et al., 1992 
Threonyl- No ? Shimizu et al., 1992 
Valyl- Yes Yes Tamura et al., 1991 a, Pallanck, Li, & 
Schulman, pers. comm. 
Tryptophanyl- Yes Yes Himeno et al., 1991, Pak et al., 1992. 
Tyrosyl- Yes ? Himeno et al., 1990 
; Based on results of assay with E. coli phenylalanyl-tRNA synthetase and E 
coli tRNAPhe . Assays with the same synthetase but in a yeast tRNAPhe 
background suggest that the discriminator is a recognition element. 
§ Based on reduction of suppression efficiency 
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Table IV 













































McClain & Foss, 1988a, McClain et al., 
1991 b, Tamura et al., 1991 b 
McClain & Foss, 1988a, McClain & Foss, 
1988c, McClain & Foss, 1988d, Peterson & 
Uhlenbeck, 1992 
Rould et al., 1991 
McClain & Foss, 1988b, Schulman & Pelka, 
1989, McClain & Foss, 1990, Tamura et al., 
1992, 
Himeno et al., 1990 
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Table V 
Unusual elements used In tRNA discrimination by E. coli 
amlnoacyl-tRNA synthetases 
Synthetase Element in vitro in vivo References 
Phenylalanyl- central core Yes ? Peterson & Uhlenbeck, 1992 
Histidyl- nucleotide -1 Yes ? Himeno et al., 1989 
Francklyn & Schimmel, 1990 
Francklyn et al., 1992 
lsoleucyl- Lysidine 34 Yes Yes Maramatsu et al., 1988, 
Pallanck & Schulman, 1991 
Lysyl- mnm5s2U 34 Yes ? Tamura et al., 1992 
Glutaminyl- G1 0 (D-stem) Yes ? Rould et al., 1989, Jahn et 
al., 1991 , Hayase et al., 1992 
Seryl- C11 :G24 ? Yes Normanly et al.' 1986a, 
Normanly et al., 1992 
Seryl- Variable loop Yes Yes Himeno et al., 1990, 
Normanly et al., 1992 
Tyrosyl Variable loop Yes Yes Himeno et al., 1990, 
Normanly et al., 1992 
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Figure legends: 
Figure 1: Sequence of yeast tRNAPhe shown in the cloverleaf representation 
of the secondary structure of all tRNAs. Important secondary structural 
domains are labeled. 
Figure 2: Tertiary structure of yeast tRNAPhe (Kim et al., 1974). A) Three-
dimensional structure of yeast tRNAPhe showing the location of the 
secondary structural domains and the variable pocket (drawing courtesy of 
J . Sampson). B) Cloverleaf representation of yeast tRNAPhe showing 
tertiary interactions required to produce the three-dimensional structure 
shown in Figure 2A. Important interactions are indicated by name. The 
nucleotides which make up the variable pocket are circled. The tertiary 
interaction which involves A21 is with the phosphate backbone of U8. 
Figure 3: Recognition and identity elements of tRNAAia. Circles with 
nucleotides labeled are recognition elements. Squares indicate identity 
elements. (*) Identity element G1 :C72 has not been tested for effects on 
recognition in vitro. 
Figure 4: Recognition and identity elements of E. coli tRNAPhe. Circles with 
nucleotides indicated are recognition elements. Squares indicate identity 
elements. The propeller twist nucleotides 26:44, were always co-mutated. (*) 
Recognition elements G1 0, C25 and A26 have not been tested for in vivo 
effects; recognition elements G34 & A35 have not been tested in the in vivo 
initiation system (although they were mutated without effect in amber 
suppression system). 
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Figure 5: Recognition and identity elements of E. coli tRNAGin and contact 
points for the glutaminyl-tRNA synthetase. Modified nucleotides are listed as 
the parent nucleotide. Circles, recognition or identity elements; squares, 
nucleotide specific contacts between the synthetase and tRNA. Dashed lines 
indicate base pairing interactions required for specific recognition. Base pair 
1:72 and the discriminator do not have nucleotide specific contacts with the 
synthetase, but are required for the assumption of an optimal conformation 
for aminoacylation (see text). (*) U32 and U33 are believed to be involved in 
maintaining the structure of the anticodon region (see text) but have not 
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In vivo studies of the Identity of tRNACys In Escherichia coli 
Portions of the work described herein appeared in Komatsoulis, G. A., and 
Abelson, J . N. (1993) Biochemistry submitted 
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Abstract: 
Eight amber suppressor tRNAs which were hybrids of tRNACys and 
tRNAAia (UGC) were constructed in an effort to determine the nature and 
location of the elements required to confer cysteine identity in vivo. A wild-type 
amber suppressor tRNACys retains its cysteine identity in vivo (94% Cys, 6% 
Gin), but when three base pairs in the anticodon stem are mutated to the 
alanine sequence, the level of cysteine identity is reduced dramatically (37% 
Cys, 63% Gin). When the base pairs are mutated individually, cysteine identity 
is retained (89-93% Cys, 5 to 11% Gin). These results suggest that the wild-type 
amber suppressor tRNACys is already seriously impaired for aminoacylation by 
the cysteinyl-tRNA synthetase in vivo, and that the anticodon stem mutations are 
fine-tuning the competition between the cysteinyl- and glutaminyl- tRNA 
synthetases. In vitro aminoacylation experiments will be required to verify these 




The scientific study of transfer RNA identity, the process of determining 
what sequence or structural elements within a tRNA are required to define a 
specific amino acid acceptance in vivo, has undergone a renaissance in recent 
years driven by advances in molecular biology. The application of the Merrifield 
technique to automated oligonucleotide synthesis has allowed the rapid and 
simple construction of any desired tRNA sequence, and new molecular biology 
techniques have advanced the methods used to determine the amino-acid-
acceptance of a tRNA in vivo. 
One way of determining the amino-acid-specificity of a tRNA involves 
amber or opal suppressors and reporter genes with nonsense mutations. Many 
proteins have positions which are specific for only one or two amino acids ; other 
amino acids at these positions produce nonfunctional products. Thus, 
aminoacylation of a nonsense suppressor with a particular specificity can be 
tested by assaying for active protein produced from a gene with an amber or 
opal mutation at the amino acid restricted site. One example of such a genetic 
test involves the B-lactamase gene; which has been subjected to extensive site 
directed mutatgenesis (Dalbadie-McFarland et al., 1982). Rescue of an amber 
mutation at the active site of this gene requires that the suppressor tRNA insert 
serine or cysteine. Other examples include suppression of an amber mutation at 
the active site of the thymidylate synthetase gene, which requires cysteine for 
reasonable activity (Dev et al., 1988, Michaels et al., 1990), and the lacZ1 ooo 
amber mutation in strain BT235, which can be suppressed by glutamine (or 
several other amino acids) but not by serine. The approximate amino-acid-
specificity for an amber suppressor tRNA can thus be easily determined by 
assaying for functional compensation of amber mutants sites specific for the 
twenty different amino acids. 
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An alternative approach to test the amino-acid-specificity of an amber 
suppressor tRNA is to simply sequence the protein product of the reporter gene. 
The relative amount of any amino acid found at the site of the amber mutation 
would then give an indication of the frequency with which the various 
aminoacyl-tRNA synthetases were charging the tRNA. The reporter gene which 
is most commonly (and originally) used is the fo/amber1 o gene from E. coli, 
(Normanly et al., 1986a, 1986b) which produces Dihydrofolate Reductase 
(DHFR). DHFR was chosen because it can be easily purified by methotrexate 
affinity chromatography and anion exchange chromatography. The approximate 
level of aminoacylation by any given synthetase can then be determined from 
the relative amount of the corresponding amino acid at position 10. 
The first use of these new methods was by Normanly and coworkers 
(1986a), who successfully converted a naturally occurring leucine amber 
suppressor tRNA into a serine specific amber suppressor. Later that year 
Normanly et al. (1986b) created two amber suppressor tRNAs which did not 
exist in nature, one specific for phenylalanine and one specific for cysteine. 
Other systems were rapidly investigated using these methods (for review see 
Schimmel, 1987, Normanly and Abelson, 1989, and Schulman, 1991) These 
methods did not work with all tRNAs however; an attempt to produce a set of 
amber suppressor tRNAs for all twenty amino acids produced 11 functional 
suppressors which retained their identity, and 8 suppressor tRNAs which 
inserted significant amounts of glutamine or lysine, presumably because the 
anticodon was a significant determinant of in vivo identity in many tRNAs 
(Normanly et al., 1990, and Kleina et al., 1990). Recently, Chattapadhyay 
(1990) et al. described a new method based on initiation rather than amber 
suppression, which allows in vivo studies of tRNAs which use the anticodon as 
an identity element. 
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Despite the early experiments of Normanly et al. (1986b) showing that a 
wild-type cysteine amber suppressor retains cysteine identity in vivo, no further 
work had been reported when this study was begun. There is a single cysteine 
accepting tRNA in E. coli with anticodon GCA which recognizes two codons 
UGC and UGU (Komine et al., 1990, Sprinzl et al., 1991 ). Although this prevents 
using comparisons of isoacceptors to help guess identity nucleotides (see 
McClain and Nicholas Jr., 1987) there were several advantages to working with 
cysteine. A genetic screen specific for cysteine was available (Michaels et al., 
1990, and C. Kim and J. Miller, pers. comm.) and the amber suppressor 
tRNACys (Normanly et al., 1986b) provided a good starting point for study. 
Furthermore, the cysteinyl-tRNA synthetase, originally characterized by 
Bohmann and lsaksson (1979) was cloned and sequenced shortly after these 
studies began (Eriani et al., 1991, Hou et al., 1991 ), making possible the future 
application of in vitro aminoacylation experiments. We therefore sought to 
determine the identity elements of E. co/itRNACYs. 
Materials and Methods: 
Strains and plasmids: 
Strain XAC-1 is F' lac/lacZam I argEam gyrA rpoB Ll(lac pro) ara. JM1 01 is 
F'traD36 proAB laclqZMt5 lt1(/ac pro) supE thi. E. coli strain i-p+ is F' 
/acpro/Ll(lacpro) thi. Both were obtained from J. Normanly. XAC6TK is F- lt1(fac 
pro) ara gyrA rpoB argEam nal thi LlthyA recA ::Tn 10 and was obtained from 
Choll W. Kim (UCLA). Plasmids pGFIB-1 and pDaYQ are described in Normanly 
et al. (1986b) and (1990) respectively. Plasmid pThyA is pACYC184 with 
ThyAamber166 cloned into the Hindlll site and was the gift of Choll W . Kim 
(UCLA). 
Cloning of tRNA genes: 
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Genes for tRNAs were constructed from six oligonucleotides and cloned 
into the EcoRI-Pstl sites in pGFIB-1 under the control of an lpp (lippoprotein) 
promoter and rrnC terminator (Normanly et al., 1986b). The lpp promoter is a 
strong constitutively on promoter; rrnC is a rho-independent terminator from the 
risbosomal RNA genes. Each tRNA gene included a T7 RNA polymerase 
promoter, the tRNA gene itself , and a BstNI site which included the terminal 
CCA of the tRNA (see Figure 1 ). Annealing of the oligonucleotides and cloning 
were carried out according to the methods of Normanly et al.(1986a). Once 
cloned and sequenced (Sanger et al., 1977) the tRNA was transformed into 
appropriate strains for characterization. 
Genetic methods of studying In vivo Identity: 
The initial determination that the tRNA was a functional amber 
suppressor was the ability to suppress the amber mutations in the lacl/lacZ 
fusion and argE genes in strain XAC-1. The former was assayed by production 
of a blue color on indicator plates containing isopropyi-B-0-galactopyranoside 
(IPTG) and X-gal ; the latter by assaying for growth on minimal media lacking 
arginine (Miller, 1972). Suppression efficiency was assayed by determining B-
galactosidase levels produced from the episomal lacllacZamber fusion in strain 
XAC-1 by the cloned amber suppressor tRNA and then comparing this value 
with levels produced in a wild-type strain, E. coli 1-p+. B-galactosidase activity 
was determined using the method of Miller (1972). The cysteine specific amber 
suppression assay (Michaels et al., 1990 and C. W. Kim and J. Miller, pers. 
comm.) utilized a cysteine requiring amber mutation in the thymidylate 
synthetase gene (Dev et al., 1988). It was carried out by transforming a plasmid 
containing the suppressor tRNA of interest and pThyA (with the thyAamber 
gene) into strain XAC6 TK (which is Thy-) and assaying for growth on minimal 
M9 medium (Miller, 1972) without thymidine. To verify that the results were 
45 
caused by the suppressor tRNA of interest in the correct strain, the proline 
auxotrophy and argEamber mutation were tested in parallel. 
DHFR assays: 
DHFR expression and purification was performed using a variation of the 
method described by Normanly et al. (1986a). DHFR was purified from XAC-1 
cells using a compatible plasmid system. The two plasmids were 
pGFIB::suppressor-tRNA, and pDaYQ which contained fo/amber1 o. the mutant 
DHFR gene .. Cells were grown until A600 reached 0.6 and then induced with 
1 mM IPTG and grown for another 8 hours. After recovery, cells were 
resuspended in 40mM Tris pH8.0 and then frozen in liquid nitrogen. Lysis was 
by lysozyme-Brij58 treatment, after which the extract was treated with DNAsel. A 
50% ammonium sulfate cut was performed on the extract, followed by a 100% 
cut on the supernatant. The pellet was resuspended in dialysis buffer (SOmM 
potassium phosphate pH6.0, 200mM KCI, 500J..LM EDTA, 1 mM DTT), mixed with 
3mL methotrexate sepharose (Pierce) and dialyzed overnight. The 
methotrexate sepharose was then batch washed or washed in column with 
200mM potassium phosphate pH 6.0, 1M KCI, 1 mM DTT. The DHFR was eluted 
with folic acid (200mM potassium borate pH9.0, 1M KCI , 1 mM DTT, 1 mM 
EDTA, 2mM fol ic acid). Protein-containing fractions were combined and 
dialyzed against KP8 buffer (50mM potassium phosphate pH8.0, 1 mM DTT). 
The DHFR was purified away from nucleic acids, other proteins, and folic acid 
by MonoO™ FPLC using a linear gradient from 0 to 400mM KCI with a slope of 
16mM KCI/min at a flow rate of 1 mUmin. Fractions containing DHFR were 
pooled, dialyzed against 1 mM DTT, and then concentrated with a Centricon1 0 
filter unit (Amicon). The protein was derivatized and sequenced at the Caltech 
Biopolymer Synthesis and Analysis Resource Center, Protein/Peptide 
Sequencing Laboratory. To more accurately quantitate cysteine, the DHFR was 
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first pyridylethylated and purified on reverse phase C18 HPLC (D. Teplow and 
T. Bauer, pers. comm.) before sequencing. 
Results: 
Construction and In vivo studies of amber suppressor mutants of 
tRNACys: 
To begin a study of cysteine identity and recognition a cysteine amber 
suppressor tRNA (CysCUA) was constructed in plasmid pGFIB-1. Such a gene 
had been constructed before (Normanly et al. , 1986b) but it did not contain a T7 
promoter (for later in vitro studies) and its identity had been assayed using a-
galactosidase (rather than DHFR) as the reporter gene. The suppression 
efficiency for the new amber suppressor tRNA was 11-24%, which is consistent 
with the results (17-50%) of Normanly et al., 1986b. The ability of tRNA CysCUA 
to suppress a mutant with an amber codon in the cysteine requiring active site 
of thymidylate synthetase indicates that it is charged at some level by cysteine 
although the assay does not indicate whether other aminoacyl-tRNA 
synthetases are also charging the tRNA. To determine the complete identity of 
CysCUA, a second plasmid, pDaYQ which contains the fo/amber1 o gene under 
the control of a tac promoter, was transformed into the strain carrying 
pGFIB:CysCUA, and DHFR protein was purified and sequenced. The relative 
ability of the various synthetases to aminoacylate the tRNA is reflected as the 
amino acid composition of the protein at position 1 0; for CysCUA the results 
were 94% Cys, 6% Gin (Table 1 ). These results independently confirm the 
results of Normanly et al., (1986b) that CysCUA retains its cysteine identity in 
vivo. 
Construction and in vivo studies of acm1 to acm4: 
Since the amber suppressor tRNACys had retained its in vivo identity a 
series of tRNAs was constructed to attempt to define the minimal set of elements 
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required to specify a cysteine tRNA. These elements would be identified by their 
ability to confer cysteine identity on an amber suppressor tRNAAia, and so the 
tRNAs were labelled acm, Alanine to Cysteine Mutants. Alanine (see figure 3 for 
sequence) was chosen as the heterologous tRNA for several reasons; its main 
identity element, a G-U base pair at position 3 :70 (all numbering of tRNAs 
follows Sprinzl et al., 1991) had been described, making the problem of 
eliminating alanine identity easier. Furthermore, when this G-U pair was 
introduced into an amber suppressor tRNACys the result was an alanine tRNA, 
suggesting that the overall structure of the two tRNAs were not incompatible. In 
order to ensure that all of the tRNAs were efficient suppressors, nucleotide 38 
was mutated from C to A to better conform to the extended anticodon rule 
(Varus 1982). This meant however that all of the acm tRNAs contained a 
cysteine element (A38) in the anticodon loop. 
The first two tRNAs of this series (acm1 and acm2) were designed to 
rapidly determine the approximate size and location of the identity set elements. 
Acm1 (figure 4), has only a few residues in a single region, the acceptor stem 
changed to cysteine sequence ; while acm2 (figure 5), would have cysteine 
sequence in all but the anticodon stem. If both were charged only with cysteine 
future experiments could concentrate on the acceptor stem only; if acm2 was 
charged specifically with cysteine but acm1 was not then other regions of the 
tRNA would need to be studied as well. 
The two tRNAs, acm1 and acm2, were cloned into pGFIB-1 and the initial 
genetic experiments performed. Both were functional suppressors, able to 
suppress the /acllacZamber and argEamber mutations of strain XAC-1 . Their 
suppression efficiencies were calculated to be 0.6% and 11 -24% respectively 
(Table 1). Both were tested for suppression of the cysteine specific thyAamber 
mutant, but only acm2 was able to grow in the absence of thymidine. This did 
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not necessarily indicate that acm1 was being charged with no cysteine. The 
suppression efficiency of this tRNA was sufficiently low that several days were 
required for growth without arginine in strain XAC-1; the result with the 
thyAamber might simply be the combination of a bad suppressor and a multiple 
in vivo identity. 
Two new tRNAs which incorporated more cysteine sequence were 
designed and cloned in an effort to correct whatever defects were causing the 
poor suppression efficiency of acm1. New tRNA acm3 (figure 6) has cysteine 
sequences in the acceptor stem, D stem and loop, and variable loop, and 
alanine sequences in the T'PC stem and loop, and anticodon stem. Acm4 
(figure 7) has cysteine sequence in the acceptor stem and D loop, and alanine 
sequences in the D stem, T'PC stem and loop, variable loop, and anticodon 
stem. In both of these tRNAs base pairs 6:67 and 7:66 (at the bottom of the 
acceptor stem) retain the alanine sequence in order to preserve any stacking 
interactions with the alanine T'PC stem. These two tRNAs were extremely 
inefficient suppressors, incapable of suppressing the argEamber mutation in 
XAC-1 . (Table I) Their calculated suppression efficiencies were 0.01% for acm3 
and 0.001% for acm4. The cysteine specific thymidylate synthetase assay was 
never attempted. 
In order to determine the full range of synthetases which could 
aminoacylate acm2, the tRNA was used to suppress the fo/amber1 o mutation. 
The sequenced DHFR protein indicated that acm2 was aminoacylated with 37% 
cysteine and 63% glutamine (Table 1). Thus, it appeared that one or more of the 
six anticodon stem nucleotides which differed between tRNAAia and tRNACys 
might be identity elements. 
Construction and analysis of anticodon stem mutations: 
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To determine which base pair(s) in the anticodon stem was the identity 
element(s), three mutant tRNAs were constructed. Each tRNA is a cysteine tRNA 
in which one of the three base pairs which are different between tRNAAia and 
tRNACys changed to the alanine sequence. Mutant acm5 (figure 8) has 
cysteine base pair A31 :'1'39 changed to C31 :G39; acm7 (figure 9) has cysteine 
base pair G29:C41 mutated to U29:A41, and acm8 (figure10) has G27:U41 
mutated to C27:G41 . All three tRNAs suppressed the argEamber and 
lacllacZamber fusion, with suppression efficiencies of 4%, 9%, and 20% 
respectively (Table 1). All were aminoacylated to some extent with cysteine as 
determined by their ability to suppress the thymidylate synthetase amber 
mutation (Table 1). 
The results of the DHFR assay for these suppressor tRNAs are shown in 
Table I. All three suppressors inserted primarily cysteine with lesser amounts of 
glutamine. The aminoacylation pattern resembles that of CysCUA, the wild-type 
amber suppressor. All four tRNAs (CysCUA, acm5, acm7, and acm8) retain their 
identity, the variations were within the error of the assay. 
Discussion: 
The results of the in vivo studies presented here do not form a coherent 
data set on the surface. CysCUA, the wild-type amber suppressor tRNACys is a 
reasonably efficient suppressor tRNA which retains its identity in vivo (94% Cys, 
6% Gin). When the anticodon stem of this tRNA is mutated to the sequence of 
an alanine tRNA its in vivo cysteine identity is partially lost and the new tRNA, 
acm2, is charged primarily with glutamine (63%) with a smaller amount of 
cysteine. This would seem to suggest that one (or more) of the three anticodon 
stem base pairs changed in acm2 was an identity element, and presumably the 
element(s) could be identified by changing each of the base pairs individually 
and assaying for cysteine identity. When this was done however, all of the 
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tRNAs (acm5, acm7, and acm8) retained their cysteine identities just like the 
wild-type amber suppressor tRNA. 
This data only makes sense if the anticodon is an important identity 
element for the cysteinyl-tRNA synthetase, but can be mutated without changing 
the identity of the tRNA. This theory postulates that the amber supressor 
tRNACys is a much worse substrate for the cysteinyHRNA synthetase than a 
wild-type tRNA with the GCA anticodon, but retains cysteine identity because no 
other synthetase can compete successfully with the cognate synthetase 
(although the presence of 6% glutamine in the DHFR from CysCUA suggests 
that the glutaminyHRNA synthetase is beginning to compete successfully for the 
tRNA, see Sherman et al., 1992 for an interesting paper showing the effects of 
synthetase competition). Thus CysCUA is sitting on the knife edge, a relatively 
small change in the total catalytic efficiency with either synthetase is enough to 
produce large changes in identity. The sum of six mutations in acm2 might 
marginally increase the catalytic efficiency with the glutaminyl-tRNA synthetase, 
while mutations in each individual base pair (acm5, acm7, and acm8) cannot. 
Alternatively, the sum of the mutations might reduce the total catalytic efficiency 
of the reaction with the cysteinyHRNA synthetase, while the individual 
mutations cannot. One possible source for the changes in catalytic efficiency 
could be the effect of the anticodon stem on the position of the anticodon 
nucleotides with regard to the recognition site on the synthetases. 
Regardless, the only way to ascertain which of these hypotheses is 
correct is to perform in vitro aminoacylation experiments on these tRNAs. In 
particular it will be necessary to evaluate the importance of the anticodon in 
recognition of tRNACys_ 
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Figure 1: Graphic representation of a typical tRNA gene construction used in 
these studies. 
Figure 2: RNA sequence of the amber suppressor tRNACYs. Modifications are 
inferred from the sequence of the wild-type tRNA (Sprinzl et al., 1991 ). 
Figure 3: RNA sequence of tRNAAia, modified nucleotides shown as parent 
nucleotides 
Figure 4: RNA sequence of mutant acm1, shown as changes from tRNAAia. 
Modified nucleotides shown as parent nucleotides. 
Figure 5: RNA sequence of mutant acm2, shown as changes from tRNAAia. 
Modified nucleotides shown as parent nucleotides. 
Figure 6: RNA sequence of mutant acm3, shown as changes from tRNAAia. 
Modified nucleotides shown as parent nucleotides. 
Figure 7 : RNA sequence of mutant acm4, shown as changes from tRNAAia. 
Modified nucleotides shown as parent nucleotides. 
Figure 8: RNA sequence of mutant acmS, shown as changes from tRNACYS. 
Modified nucleotides shown as parent nucleotides. 
Figure 9: RNA sequence of mutant acm7, shown as changes from tRNACYs. 
Modified nucleotides shown as parent nucleotides. 
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Figure 10: RNA sequence of mutant acm8, shown as changes from tRNACYS. 
Modified nucleotides shown as parent nucleotides. 
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Figure 1 


















eGA sUU AA G A A c AA G G c c u c A 
G D D A U G U GU C C G G G A A T F C 





















cG A U ~ Acu C G AU A C G CCC U A 




















C• G U ~G 
G C 
C G 
~ AA A U A 
t cG A t t \ ~ U A C G C C C U A 
~ CU eGA UGCGG G 
G<? AG A G c C --.(3c U u C 
~ ~l ~ j/c GA~,~ 
UU A C G "''-...._uA 
U A C 
G C 
C G 
U C ... A 
UU CA 
1 G J 
6 ~A 










~ U A 
tcGA A U ~ C U C G AU A C G C C C U A 
G'? A G A G c g G C G G G ~* G U UuC 





U C •A 
u U CA 













C G A UU A G A A C AA A G G C C U C A 
G U U A U G U GU C C G G G A A U U C 




c~ A u •G 
U A 
u G AA 
~ c 















C G A A A C AA U C C G G U U C 
G AUGU GA 
GuU A cU 
G U 
C G 





















C G A A A C AA U C C G G U U C 
G AUGU GA 












In vitro studies of the recognition of tRNACys by the E. coli cysteinyl-tRNA 
synthetase 




A study of the recognition of tRNACys by E. coli cysteinyl-tRNA 
synthetase using in vitro methods was performed. All three anticodon 
nucleotides, the discriminator U73, and some element within the tertiary domain 
(the D stem/loop, the T'I'C stem/loop and extra loop) are important for 
recognition; the anticodon stem and acceptor stem appear to contain no essential 
elements. A T7 RNA polymerase transcribed tRNA is a six-fold worse substrate 
(in terms of the selectivity constant, kcat/Km) mainly due to an increase in Km. 
This may reflect recognition of modified nucleotides or subtle effects on the 
folding of the tRNA. The greatest loss of specificity caused by mutation of a 
single nucleotide occurs when the discriminator U73 is changed ; kcat/Km 
declines 3 to 4 orders of magnitude depending on the substitution. Mutations in 
the wobble nucleotide of the anticodon also cause reductions in the selectivity 
constant of 3 orders of magnitude, while mutations in the other anticodon 
nucleotides caused lesser effects. Interestingly, a C35A mutation had no effect 
on aminoacylation by the cysteinyl-tRNA synthetase. Several amber suppressor 
tRNAs were constructed whose in vivo identity did not correlate with their in vitro 
specificity, indicating the need for both types of experiments to understand the 
factor(s) which maintain tRNA specificity. 
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Introduction: 
The obvious alternative to in vivo experiments such as described in the 
previous chapter is to aminoacylate purified tRNAs in vitro with purified (or 
partially purified) aminoacyl-tRNA synthetases and then calculate the kinetic 
parameters for the reaction (for review see Schulman, 1991 ). These sorts of 
experiments can generate much useful information both in terms of how 
important an element is for recognition, and how that element mediates its effect. 
The former is usually measured by observing the effect of a mutation on the 
value of kcat/Km for the tRNA; this number is often called the selectivity constant 
and represents the total catalytic efficiency of the reaction. The individual 
components of the selectivity constant indicate whether an effect is mediated 
through binding of the substrate (Km) or the formation of the transition state 
(kcat). 
Although in vitro aminoacylation experiments have been conducted for 
many years (see for instance Abelson et al., 1970, Squires and Carbon, 1971) 
their utility in tRNA recognition had been severely limited due to the difficulty of 
preparing mutant substrates. Early methods used chemical or enzymatic 
(Schulman and Pelka, 1983) methods to make mutations in pre-existing tRNAs, 
but this was time consuming and difficult to use in a site specific fashion. The 
advent of molecular cloning techniques allowed a researcher to make specific 
mutations in a tRNA and then overexpress that tRNA in vivo, but the purification 
was still clumsy and time consuming. 
This difficulty was overcome by improvements in the understanding of 
promoters and reaction conditions for bacteriophage RNA polymerases. The 
RNA polymerase from phage T7 seemed particularly well suited to the purpose of 
transcribing mutant tRNA molecules, its promoter preferences were well 
characterized, and it initiates at the + 1 site downstream from its promoter with 
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excellent accuracy (Milligan et al., 1987). Sampson and Uhlenbeck (1988) were 
the first to report on the aminoacylation of a yeast tRNAPhe produced by 
transcription with T7 RNA polymerase. The tRNA gene had been cloned with a 
T7 promoter just proximal to the 5' end of the tRNA molecule, and they converted 
the CCA terminus to a BstNI site by the addition of a GG dinucleotide. Thus, by 
cutting the plasmid with BstNI they generated a template from which an 
unmodified tRNA with the proper CCA terminus could be produced. At 15mM 
MgCI2 the T7 transcribed tRNA behaved very similarly to the fully modified tRNA, 
with only a 4-fold increase in Km and a slight reduction in kcat giving a change in 
the selectivity constant kcat/Km. of only 5-fold. The thermal melting profile of the 
two tRNAs suggested that the difference was caused by a slightly looser 
structure on the part of the T7 transcript. They showed the utility of this method 
by rapidly preparing and analyzing a tRNA with a mutation in nucleotide 20, 
which had been shown previously to be important for recognition by the 
phenylalanyl-tRNA synthetase. This approach has since been extended in the 
Uhlenbeck laboratory, and the recognition elements of both yeast (Sampson et 
al., 1990, Sampson et al., 1992) and E. coli (Peterson et al., 1992) tRNAPhe 
have been studied extensively by this method. Since then many laboratories 
have adopted this approach for studies of tRNA recognition (review: Schulman, 
1991) 
A cloned synthetase is a useful tool in in vitro aminoacylation studies, and 
fortunately the E. coli cysteinyl -tRNA synthetase had been cloned and 
sequenced by two laboratories (Hou et al., 1991, Eriani et al., 1991) by 
complementation of a temperature sensitive mutant (Bohmann and lsaksson, 
1979). The sequence indicates that the monomer unit is a peptide of 461 amino 
acids with a molecular weight of 52.3 kD and is a synthetase of type I (Hou et al., 
1991, Eriani et al., 1991 ). Type I synthetases contain two conserved sequences 
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HIGH and KMSKS, which are indicative of the Rossman fold, a structural motif 
corresponding to an ATP binding domain (Eriani et al., 1990, reviewed in Moras, 
1992). 
The confusing in vivo results observed with mutant E. coli cysteine tRNAs 
suggested that in vitro aminoacylation experiments would be required to identify 
the elements important to define a tRNA as cysteine. Furthermore, if the 
anticodon was as important for recognition and identity as the in vivo experiments 
suggested, all future experiments would have to be performed in vitro since most 
in vivo methods rely on amber or opal suppressors. For this reason the cysteinyl-
tRNA synthetase was partially purified from an overproducing strain and used to 
conduct a study of the recognition of tRNACys (Figure 1 A), initially focusing on 
the amber suppressor tRNAs described in the previous section. 
Materials and Methods: 
Strains and plasmlds: 
Strain XAC-1 is F' lacl373lacZu118am proS+ I !!.(lac pro)x111 argEam 
gyrA rpoB ara. JM1 01 is F'traD36 proAB lacJCIZM15 /!!.(lac pro) supE thi. E. coli 
strain i-p+ is F' lacprol!l(lacpro)x111 thi. Both were obtained from J. Normanly. 
Plasmids pGFIB-1 and pDaYQ are described in Normanly et al. (1986a) and 
(1990) respectively. Plasmid pCysS containing the cysteinyl-tRNA synthetase is 
the gift of G. Eriani and J. Gangloff (CNRS, Strasbourg, France). 
Design and cloning of tRNA genes: 
Genes for tRNAs were constructed from six oligonucleotides and cloned 
into the EcoRI-Pstl sites in pGFIB-1 if the tRNA was to be used in vivo, or pUC18 
if the tRNA was to be used solely in vitro. The exceptions to this rule are tRNAs 
Cys73A and CysGCA, which were cloned into pGFIB-1 and CysGAA which was 
cloned into pUC19. Each tRNA gene included a T7 RNA polymerase promoter, 
the tRNA gene itself, and a downstream BstNI site to produce the terminal CCA 
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of the tRNA (see figure 1 B). Annealing and ligation of the oligonucleotides and 
cloning were carried out according to the methods of Normanly et a1.(1986b). All 
tRNAs were sequenced using the dideoxy method of Sanger et al. (1977). 
Purification of the cysteinyl-tRNA synthetase (CysRS): 
Cysteinyl-tRNA synthetase was purified from an overproducing strain of 
JM1 01 which carried plasmid pCysS (Eriani et al., 1991 ), using a variation on the 
method of Hou et al. (1991 ). Two liters of cells were grown to an Asoo of 2 in LB 
medium supplemented with 1 OOJ.Lg/ml of ampicillin, harvested, and resuspended 
in 20 ml lysis buffer (50mM Tris pH7.6, 1 mM EDTA, 1 mM OTT, 500J.!M PMSF). 
The cells were washed twice in lysis buffer, sonicated and centrifuged at 1 00,000 
times g (40,000 RPM in a Beckman 70.1 Ti rotor} for one hour at 4°C. The S1 00 
extract was loaded onto a Q-sepharose™ column which had been equilibrated 
with 50mM Tris pH7.6, MgCI2 1 mM EDTA, 1 mM OTT, 500~M PMSF and washed 
with 158ml of this buffer. CysRS was eluted with a linear gradient of 0-500mM 
KCI with a slope of 6.7mM KCI/min and a flow rate of 2 mUmin. Fifty 3ml 
fractions were collected; six active fractions were pooled and dialyzed against 
50mM Tris pH7.6, 1 OmM MgCI2, 10% glycerol, 1 mM OTT, 500J.!M PMSF, 
concentrated with a Centricon1 0 filter unit (Amicon), increased to 50% glycerol, 
and stored at -20°C. The final protein concentration was 13~g/~L. and the activity 
was 590units/mg protein (unit definition: 1 nmole aminoacylated native tRNACys 
per minute). The synthetase was approximately 25 to 50% pure, and was judged 
free of RNAse activity by incubating it under aminoacylation conditions (15mM 
MgCI2 rather than the usual 7mM) with 5J.!M native tRNA Cys (Subriden RNA) for 
1 hour at 37°C, and then checking for degradation products on a 10% 
polyacrylamide (29:1 crosslink ratio), 8M urea, 1 X TBE gel. 
In vitro transcription of tRNAs: 
Plasmid DNA was prepared using CsCI gradients, or by anion exchange 
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chromatography (with Qiagen <plasmid> tip 500 columns). Plasmids were then 
digested with restriction endonuclease BstNI , extracted twice with 
phenol/chloroform/isoamyl alcohol (25/24/1 ), extracted once with chloroform, 
precipitated, and recovered in TE8 (1 OmM Tris pH8.0, 1 mM EDTA). 
Transcriptions used the following conditions: 0.1 J..Lg/ J..LL digested DNA, 40mM 
Tris pH8.3, 20mM MgCI2, 1 mM spermidine, 5mM OTT, 5mM each NTP 
(Pharmacia), 1 OmM GMP (Pharmacia) , 50J..Lg/ml acetylated BSA (New England 
Biolabs), 7u/ml pyrophosphatase (Sigma), 0.8 u/J..LL RNAsin (preincubated 20 
minutes on ice with 20mM OTT), and 26u/J..LL T7 RNA polymerase (prepared by 
M. Saks and J . Sampson). Reactions were incubated for 4 to 5 hours at 37° C. 
Transcription reactions were terminated by adding 1/20 volume 0.5M EDTA and 
1/10 volume 3M NaOAc, and were then extracted with phenol equilibrated with 
300mM NaOAc pH5.3. The RNA was precipitated overnight at -20° C after 
adding 3 volumes ice cold ethanol. 
The products were recovered in TE7.5 (1 OmM Tris pH7.5, 1 mM EDTA) 
and mixed with equal volumes of RNA loading buffer heated to 85-90° C for 3 
minutes, and then loaded onto 40 em long denaturing 8% polyacrylamide (19:1 
crosslink ratio) gels (except for AS1 and AS2, which were purified on 10% 
polyacrylamide, 29:1 crosslink gels). Gels were run at 600-900V. RNA was 
visualized by UV shadowing, excised from the gel, and eluted twice with 200mM 
KOAc pH5.4, 1 OmM EDTA at 4° C. The RNA was precipitated and recovered in 
TE7.5 (10mM Tris pH7.5, 1 mM EDTA) three times. A fourth precipitation was 
carried out using 2M NH40Ac in place of 0.3M NaOAc. The RNA was dissolved 
in 1 OmM HE PES pH 7.4 and stored at -20° C. The RNA was quantitated by 
measuring the absorbance at 260nm of a nuclease digested sample (1 J..LL of 
0.9J..Lg/J..LL RNAseA, 11 u/J..LL RNAse T1, and 0.2U/J..LL RNAseT2 in 700J..LL tRNA 
sample, overnight at room temperature) at 260nM. Extinction coefficients were 
73 
calculated from the sequence of the tRNA. 
Amlnoacylatlon reactions: 
Aminoacylation reactions were performed at 37°C in 30mM HEPES pH7.4, 
2mM OTT, 15mM KCI, 7mM MgCI2, 2mM ATP, 20~M cysteine, 0.4~Ci/~L 35s-
cysteine (stabilized, SJ15232, Amersham), and cysteinyl-tRNA synthetase. 
Synthetase was used at a final dilution of 1 :200 to 1 :100,000. The final protein 
concentration in all reactions was adjusted to 0.1 ~g/~L with acetylated BSA. RNA 
and distilled H20 were prepared at 2X final concentration, and were heated to 
90°C and allowed to cool slowly before use. At appropriate time points 8~L 
samples were spotted onto 1 inch by 0.5 inch segments of Whatman 3MM paper. 
The papers had been soaked one to two days before in 10% TCA, 1 OmM OTT, 
25 ~M all amino acids except cysteine, 1 OO~M cysteine, and then allowed to dry. 
Spotted papers were soaked in 1 0% TCA, washed twice in 1 0% TCA, three times 
in 5% TCA (all 20 minutes per wash), and once in 95% ethanol (15 minutes). The 
washed papers were dried, placed in v ials with 4 ml fluor (15.3g PPO in 4L of 
Mallinkrodt ScintiiiAR toluene) and counted with a Beckman LS7800 scintillation 
counter (window 0-1 000), two minutes per sample. Several control reactions 
were performed without tRNA in order to estimate background counts. 
Data analysis: 
Backgrounds were subtracted from the counting data and aminoacylation 
rates calculated by linear regression. Enzfitter (Biosoft), a non-linear regression 
program designed for the calculation of kinetic parameters, was used to generate 
Michaelis-Menten plots and Eadie-Hofstee plots, as well as the values for kcat. 
Km, and kcat/Km. 35s-cysteine has a high rate of non-radiolytic cleavage, 
making exact determinations of specific activities difficult. Values for kcat were 
converted from cpm·min-1 to nmole·min-1 ·mg protein-1 in one of two ways: 1) An 
aminoacylation reaction with 1 ~M native tRNACys was allowed to charge to 
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completion using both 14c and 35s labelled cysteine. This could then be used to 
develop a conversion factor for cpm min-1 to nmole·min-1 ·mg protein-1. The data 
in Table Ill was converted in this fashion. 2) Using data from two reactions as 
described in (1) a standard value for kcat of a T7 transcribed tRNACys was 
determined (in nmole·min-1 ·mg protein -1 ), and a conversion factor then 
determined from the calculated value of kcat (in cpm·min-1·unit protein-1) . The 
data in Table I, II, and IV was calculated in this way. 
Results: 
Comparison of the In vitro aminoacylation kinetics of native and T7 
transcribed tRNA Cys 
Before progressing to a study of the aminoacylation kinetics of mutant 
tRNAs, it was necessary to determine if a T7 transcribed tRNA behaved similarly 
to the native, modified tRNA. Both tRNAs were aminoacylated in 30mM HEPES 
pH7.4 with 7mM Mg++, and 2mM ATP. A Mg++ titration curve indicates that 
these conditions are optimal for the T7 transcript; the native tRNA is 
aminoacylated better at lower Mg++ concentrations (data not shown). Under 
these conditions the T7 transcript has a 1.6-fold increase in kcat and a somewhat 
unusual 9.5-fold increase in Km compared to the native tRNA (Figure 2 and 
Table 1). Overall, kcat/Km for the native tRNA is increased 5.5-fold compared to 
the T7 transcript. 
In vitro studies of amber suppressor tRNACys mutants 
The wild-type amber suppressor tRNA (CysCUA) and the four mutants 
acm2, acm5, acm7, and acm8 (Figure 3) were transcribed, purified, and 
aminoacylated. Figure 4 shows the Michaelis-Menten plot for these tRNAs, and 
Table I shows the values for kcat. Km, and kcat/Km (the selectivity constant} 
associated with the various mutants. Also shown is the specificity change, the 
degree to which kcat/Km is reduced or increased compared to a wild-type 
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tRNACYs. The range of tRNA concentrations used with the amber suppressors 
was 2-20J.1M. Since the measured Km in many cases was greater than 15J.1M, 
determining the individual values of Km or kcat for many of the tRNAs required 
significant extrapolation of the Michaelis-Menten equation. Although Enzfitter 
calculated a standard error for these values, another independent determination 
of the kinetic constants could easily produce calculated values outside of these 
ranges. The qualitative effect on the individual kinetic constants (i.e., did kcat or 
Km decrease or increase) was clear, however. The value of kcat/Km does not 
require significant extrapolation of the Michaelis-Menten curve; its value can be 
calculated from the x-intercept of an Eadie-Hofstee plot. 
Compared to a wild-type transcript (CysGCA) CysCUA is reduced 3100-
fold in kcat/Km and acm2 is reduced 2400-fold; while acm5 and acm7 are 
reduced 2900- and 3500-fold respectively. Mutant acm8 is reduced 1200-fold in 
kcat/Km relative to a wild-type transcript. All mutants had a decreased value of 
kcat and an increased value of Km relative to a wild-type transcript (Table 1). 
These values for the selectivity constant, kcat/Km are not consistent with 
the in vivo identity data. Even if one considers an error of a factor of two in the 
calculation of kcat/Km, there seems to be no possible correlation between in vivo 
identity and the in vitro selectivity constant under these conditions. An Eadie-
Hofstee plot for tRNA acm2 (37% Cys) shows data points arranged in a vertical 
line, indicating a high Km but preventing direct measurement of either of the 
individual values of kcat or Km. This high value of Km may be the factor which 
causes its loss of in vivo identity. In any case, the large reductions in kcat/Km 
seen in all of the amber suppressor tRNAs suggested that the anticodon plays an 
important role in the recognition of tRNACys by the cysteinyl-tRNA synthetase. 
Effects of mutations In the anticodon and discriminator on recognition by 
cysteinyl-tRNA synthetase: 
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In order to determine the role of the anticodon nucleotides in recognition 
by the cysteinyl-tRNA synthetase, all three single base changes were made at 
each of the anticodon positions. The mutants are labeled CysXXX where XXX 
indicates the anticodon present in the tRNA. The importance of the discriminator 
nucleotide in other systems (and the fact that only one other isoaccepting group 
in E. coli, glycine, has the U73 discriminator) induced us to construct the three 
single base change mutants at this position (these mutants are labeled Cys73X 
where X is the nucleotide in the discriminator position). After transcription and gel 
purification, the kinetic parameters for these tRNAs were determined. 
Figure 5 shows the Michaelis-Menten plot for CysGCA, the reference for 
all of the anticodon and discriminator mutations. Table Ill shows the 
experimentally determined values of kcat. Km. and kcat/Km for the mutants, as 
well as the degree to which kcat/Km was reduced relative to a wild-type tRNACys 
transcript (specificity change). As with the amber suppressor tRNAs, the range of 
tRNA concentrations (1 to 20JJ.M) does not always allow the most accurate 
determination of individual values of kcat or Km, nevertheless, the qualitative 
effect of the mutation on the kinetic parameters is usually quite clear. 
Mutations in nucleotide 34, the wobble position, clearly had dramatic 
effects on the aminoacylation kinetics (Figure 6 and Table Ill). All three 
replacements caused reductions in kcat/Km of three orders of magnitude relative 
to a wild-type transcript. All three substitutions increased Km and decreased kcat. 
Nucleotide substitution at position 35 had highly variable effects (Figure 7 and 8, 
Table Ill). Interestingly, the C35A (CysGAA) mutation had essentially no effect on 
either Km or kcat. The C35U (CysGUA) and C35G (CysGGA) mutations, on the 
other hand caused reductions in kcat/Km of 320-fold and 120-fold respectively. 
Both seem to cause increases in Km and substantial reductions in kcat. Less 
dramatic effects on charging occur when nucleotide 36 is replaced (Figure 9 and 
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Table Ill). The three substitutions produce reductions in specificity of 120-, 140-, 
and 41-fold for A36U (CysGCU), A36G (CysGCG), and A36C (CysGCC) 
respectively. All of these substitutions cause reductions in kcat and increases in 
Km. 
The most dramatic effects caused by the replacement of a single 
nucleotide are seen with the substitutions at the discriminator nucleotide, position 
73 (Figure 10 and Table Ill). The U73C mutation (Cys73C) produces the best 
substrate, causing a reduction in specificity of 3200-fold compared to a wild-type 
transcript. The data suggests that this effect is primarily a kcat effect, with only a 
slight increase in Km, although this data must be interpreted cautiously due to the 
poor aminoacylation of this substrate. The U73A (Cys73A) mutant has a 13,000-
fold reduction in kcat/Km, again with a suggestion that the effect is almost 
entirely caused by a decrease in kcat. with a minor effect (about 2-fold) on Km. 
Mutant Cys73G (U73G) could not be aminoacylated to any significant degree, 
and so it presumably had an even more dramatic reduction in kcat/Km than 
Cys73A. 
Determination that elements other than the anticodon and discriminator 
contribute to recognition: 
To determine whether the anticodon is sufficient to direct aminoacylation 
by the cysteinyl-tRNA synthetase, charging reactions were carried out using the 
tRNAs shown in Figure 11 (AS1 and AS2). These tRNAs were designed and 
cloned by M. Saks and J . Sampson (pers. comm.) and are based on the tRNAAia 
(UGC) sequence with two non-alanine acceptor stems. In addition the following 
changes were made to the tRNAAia sequence: the anticodon and base pair 
31 :39 (in the anticodon stem) of alanine were replaced with those of cysteine, 
and base pair U49:A65 in the T'I'C stem was changed to A49 :U65 to promote 
better stacking interactions with the two new acceptor stems. Both tRNAs have 
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the C73 discriminator nucleotide, as opposed to the U73 discriminator found in 
tRNACYs. 
The two tRNAs were transcribed, purified and then aminoacylated under 
the standard reaction conditions. The tRNAs were not charged to any significant 
degree, despite continuing the reactions for five minutes (twice as long as a 
standard reaction), at RNA concentrations as high as 20J..LM. The presence of the 
C73 discriminator would be expected to cause a 3200-fold reduction in kcat/Km 
(see previous section), but this is measurable under the standard conditions. This 
implies that these tRNAs lack recognition elements for CysRS, or that they lack 
certain structural features which are required to allow proper interaction between 
the synthetase and recognition elements . 
Localization of other recognition elements: 
To help define the recognition elements or structural features missing from 
the AS1 and AS2 tRNAs, a set of tRNAs were designed in which structural 
domains of the cysteine tRNA were replaced by the equivalent regions from the 
AS1 tRNA. The domains (shown in Figure 12) are the acceptor stem, the 
anticodon stem and loop, and the tertiary domain (comprising the D stem and 
loop, T'I'C stem and loop, extra arm, and propeller twist nucleotides). Dividing the 
tRNA into these three domains should not affect the interactions which maintain 
the three-dimensional shape of the tRNA, which occur between nucleotides in the 
tertiary domain. Hybrid tRNAs should therefore adopt the three-dimensional 
configuration of the tRNA species which contributed the tertiary domain. 
AS1 was used as the source for heterologous sequences for several 
reasons. First, it obviously lacks recognition elements for CysRS. Second, it 
differs from tRNACys in both a sequence and structure specific fashion. tRNACys 
is a D3V4 tRNA, AS1 is type D4V5; crystalographic evidence from yeast 
tRNAAsp (see Westhof et al., 1985) suggests that D3V4 tRNAs adopt a 
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somewhat different three-dimensional conformation than D4V5 tRNAs. In 
addition, the number and location of the dihydrouridine residues which define the 
D-loop and the unusual G15:G48 Levitt pair found in tRNACys vary between 
tRNACys and AS1 . Finally, the acceptor stem of AS1 is different from that of 
tRNACys at more positions (12 of 14) than the AS2 (which is only different at 4 
positions). 
The five mutant tRNAs which were constructed are shown schematically in 
Figure 13. Three of the tRNAs are single substitutions of the domains. Two 
additional tRNAs with substitutions in two of the domains were constructed to 
investigate whether any recognition elements in the regions acted independently. 
The tRNAs are designated by the Greek letter delta followed by the name of the 
domain(s) which have been replaced with AS1 sequences (acceptor stem, 
anticodon stem/loop, or tertiary). All of the tRNAs had anticodon GCA and the 
U73 discriminator, since these are known to be recognition elements for CysRS. 
Table 4 lists the five tRNAs with their measured kinetic constants, Km, kcat. and 
kcat/Km, and Figure 14 shows the Michaelis-Menten plots for these tRNAs. 
The single domain replacement hybrids varied widely in cysteine acceptor 
activity. Replacement of the cysteine anticodon stem/loop (mutant ~anti) with the 
equivalent domain from the AS1 tRNA causes a decrease in Km from 3.8JJ.M to 
1.4 J!M, with a concomitant reduction in kcat from 1,100 to 680 nmole·min-1·mg 
protein-1. This results in a mild 1.7-fold increase in kcat/Km for aminoacylation 
as compared to a wild-type tRNACys transcript (CysGCA). Replacement of the 
tertiary domain with AS1 sequences (mutant ~tertiary) results in an increase in 
Km to 26JJ.M, and a decrease in kcat to 230 nmole·min-1·mg protein-1. The value 
of kcat/Km is thus reduced 33-fold in this mutant from that of a CysGCA 
transcript. Replacement of the acceptor stem with the AS1-U73 stem in mutant 
~ace causes an increase in Km (from 3.8JJ.M to 1 0.3JJ.M), and an insignificant 
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increase in kcat. (from 1,100 to 1,200 nmole·min-1·mg protein-1). Overall, 
kcat/Km is reduced a minor 2.4-fold compared to a wild-type cysteine transcript. 
Double replacement mutant ~acc~anti has decreased values of Km and 
kcat when compared to the single mutant ~ace, the same qualitative effects 
caused by the single mutant ~anti with regard to the wild-type tRNACYs. The 
value of kcat/Km is essentially the same as the wild-type transcript, the result 
which would be expected from two mutations cause respectively an increase of 
1.7-fold and a decrease in 2.4-fold in kcat/Km with regard to CysGCA. (Two 
mutations acting independently would be expected to cause an increase or 
decrease in kcat/Km approximately equal to the product of their individual effects, 
see Sampson et al. , 1992.) The two replacements in ~tertiary~anti cause a 
reduction in the values of kcat and Km compared to single mutant ~tertiary, 
consistent with the effects of the anticodon stem replacement on a wild-type 
transcript. However the overall effect on kcat/Km (an 81-fold reduction) caused 
by the mutations in ~tertiary~anti is not what would be predicted from two 
mutations which individually cause a 1.7-fold increase and a 33-fold reduction in 
kcat/Km. 
Discussion: 
Discrimination of tRNAs by synthetases in vivo is dictated by a 
combination of two factors; the total catalytic efficiency of the reaction with the 
cognate synthetase, and the catalytic efficiency of the reaction with the 19 
incorrect synthetases. Competition between all of the synthetases found within 
the cell ultimately defines the amino acid acceptance of a tRNA in vivo (see 
Sherman et al., 1992, Swanson et al., 1988). The elements which define the 
amino acid acceptance of a tRNA in vivo are called the identity set, and the 
overall process is tRNA identity. The elements which each of the twenty 
synthetases use to define a cognate tRNA are called the recognition set, and the 
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process is tRNA recognition . Recognition elements can act by possessing 
functional groups which interact with synthetase, or by providing a structure 
which puts another element in the proper orientation to interact with the 
synthetase. All recognition elements by definition are positive, that is, the 
presence of the element aids the creation of a productive interaction with that 
synthetase. Identity elements can be either positive or negative. A positive 
identity element would be a recognition element, assisting a productive 
interaction with the cognate synthetase. A negative element would help prevent 
productive interactions with noncognate synthetases. Negative elements are 
critical in the cell , since many synthetases use some of the same tRNA 
nucleotide elements to help recognize cognate tRNAs (Francklyn et al., 1992). 
The results of in vivo and in vitro experiments provide information on 
different aspects of the tRNA/synthetase interaction. Since in vivo experiments 
occur in a milieu where all twenty synthetases are present, they provide 
information on the nature of the identity set They cannot however distinguish 
whether a change in amino acid acceptance is caused by the removal or addition 
of a positive or negative identity element. Furthermore the necessity of working 
with amber or opal suppressors prevents direct experimentation on the effects of 
the anticodon nucleotides (although an alternate method which uses an initiation 
assay can study anticodon effects, at least within the context of an tRNAfmet 
body, see Chattapadhyay et al., 1990). In vitro experiments can only examine the 
recognition set, since the element of competition between synthetases has been 
removed. The weakness of these experiments is that they cannot detect negative 
identity elements. The two types of experiments complement each other, so that 
together it is possible to obtain a more detailed view of the process of 
tRNA/synthetase interactions. 
It is clear from the in vitro experiments that the cysteinyl-tRNA synthetase 
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uses a variety of widely spaced elements as part of its recognition set. These 
elements include the anticodon nucleotides, the discriminator nucleotide, a 
feature within the tertiary domain of the tRNA, and possibly a modified nucleotide 
or nucleotides (or a structural feature produced by a modified nucleotide). The 
results also suggest that the acceptor stem and anticodon stem play little or no 
role in recognition. Since it was not possible to make all substitutions at all 
positions in the tRNA, the possibility exists that there are undiscovered 
recognition elements within one of the domains. tRNA. The probability of 
unknown recognition elements remaining in the acceptor stem seems slight 
however, only one base pair (G1 :C72) was not changed in tRNA ~ace. 
The results of the aminoacylation reactions with native tRNACys suggest 
the possibility that one or more of the seven modified nucleotides (see Figure 1) 
may be a recognition element. Since the thymidine and pseudouridine in the T'I'C 
stem are found in all tRNAs it seems unlikely that these residues are involved. 
Any of these modified nucleotides could influence recognition by either 
possessing functional groups which interact directly with the synthetase or by 
inducing subtle variations in the folding of the tRNA. Since the native and T7 
transcribed tRNAs are aminoacylated best at different MgCI2 levels (data not 
shown) there is reason to suspect that the latter explanation is the most likely. 
The domain replacement experiments suggest that there are no 
recognition elements in the acceptor stem or anticodon stem. The minor effects 
on kcat/Km caused by these mutants are most likely caused by reorienting other 
important elements (perhaps the discriminator, CCA terminus, or the anticodon) 
or by making small changes in helix geometry or some other element of the 
tertiary structure of the molecule. It does appear that there are recognition 
elements and/or important structural features within the tertiary domain of 
tRNACYs. This is particularly interesting since the body of E. coli tRNACys may 
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have a conformation which is different from that of yeast tRNAPhe, the standard 
model for tRNA structure. E. coli tRNACys has an unusual G15:G48 Levitt pair, 
found in no other tRNA from this species (and unique to E. coli among other 
sequenced cysteine tRNAs). Sampson and Uhlenbeck (1990) found that 
replacing the G15:C48 Levitt pair in yeast tRNAPhe with the other common pair 
A 15:U48 resulted in a small, 1.6-fold decrease in kcat/Km, while replacement 
with G15:G48 caused a four-fold reduction in kcat/Km. There was an associated 
reduction in the rate of lead catalyzed tRNA cleavage, a process which is highly 
dependent upon having a yeast phenylalanine tRNA-Iike structure (Behlen et al. , 
1990). Furthermore, evidence from crystallographic (Westhof et al., 1985) and 
functional (Giege et al., 1990, Perret et al. , 1992) studies of yeast tRNAAsp 
suggest that D3V4 tRNAs (like E. coli tRNACys and yeast tRNAASP) are 
structurally distinct from D4V5 molecules like tRNAPhe. 
The element which contributed the most to cysteine recognition in vitro 
was the discriminator nucleotide, U73. The mildest mutational effect (a 3,200-fold 
reduction in kcat/Km) was seen in Cys73C, a pyrimidine/pyrimidine swap. 
Replacement of the discriminator with purines caused even more dramatic 
effects; Cys73A was reduced 13,000-fold in kcat/Km, and Cys73G was not 
significantly aminocylated under these conditions. Curiously, neither the U73A or 
U73C mutations seemed to cause large changes in the value of Km; the bulk of 
the effect appears to be on kcat (this interpretation must be viewed with some 
caution due to the poor aminoacylation of these substrates) . This is consistent 
with models by Hou and Schimmel (1989a) which postulate that most 
discrimination in vivo is based on differences in kcat. In the absence of a crystal 
structure it is impossible to determine the exact role of U73, but there are two 
obvious possibilities. One is that there is direct recognition of the single stranded 
pyrimidine. The other possibility is that it plays a role similar to that of the G73 in 
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E. coli tRNA glutamine, which participates in an intramolecular hydrogen bond 
which orients the CCA terminus (Rould et al, 1989). Mutations of the 
discriminator in tRNAGin (Jahn et al., 1991) cause reductions in kcat/Km of 
aminoacylation by the GlnRS of 2- (G73A) to 1600- (G73U) fold. The G73A 
mutation actually decreases both Km and kcat. while the other two mutations 
increase Km about 1 0-fold. 
The anticodon nucleotides also have relatively large effects on the 
aminoacylation kinetics. Mutations at nucleotide34 have the most dramatic 
effects, causing reductions in kcat/Km of three orders of magnitude, with 
reductions in kcat and increases in Km. Nucleotide 36 has lesser effects, with 
reductions of 120-, 140-, and 41-fold for A to U, G, or C substitutions. As with 
position 36, the effects appear to be mediated by both kcat and Km. The effect of 
substitutions at nucleotide 35 is more complicated. Replacement of C35 with U or 
G causes a 320- or 120-fold reduction in kcat/Km respectively, while replacement 
with A causes essentially no effect in either kcat or Km. It is ironic that the wobble 
nucleotide appears to be the most important for recognition by CysRS, since it is 
the least specific element of the codon. It is also important to note that U34 is 
generally modified in E. coli tRNAs (for review see Bjork et al., 1987); 
extrapolating the effect of the U34 mutation in vivo may therefore be difficult. 
It is interesting to compare and contrast these results with the in vivo 
results of Pallanck et al. (1992). They studied tRNACys recognition using an in 
vivo initiation system (Chattapadhyay et al. , 1990) in which the anticodon of 
interest is incorporated into tRNAfmet DHFR is then prepared from a strain in 
which the initiation codon for the to/ gene has been mutated to match the 
anticodon on the tRNAfmet The protein is then sequenced and the results 
interpreted just like an amber suppression assay. Their results were consistent 
with these experiments. They found that there was a 14-fold increase in the 
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amount of DHFR initiated with cysteine when an A73U mutation was made in 
their tRNAfmet background; the qualitative effect which would be predicted from 
these experiments. Using a U73 tRNAfmet they found that changing any of the 
anticodon nucleotides reduced cysteine acceptance in vivo, again consistent with 
these experiments. They did not test a tRNAfmetA73U with the GAA anticodon, 
but previous experiments (Chattapadhyay et al., 1990) tested it with A73. They 
found a mixture of Phe, Met, and Val (in the ratio 37:9:5), but no cysteine. Since 
the protein was not derivatized prior to sequencing it is possible that some 
amount of cysteine was present and not detected. 
The in vitro experiments indicate that not all of the mutations act 
indepedently. tRNAs which contain two independent mutations should affect 
aminoacylation efficiency (i.e. , relative kcat/Km) in proportion to the product of 
their effects when present alone. For example, a tRNA with two independent 
mutations which cause reductions in kcat/Km of 2- and 5-fold with respect to a 
wild-type tRNA, would have a value of kcat/Km which is reduced 1 0-fold with 
regard to the wild-type. The specificity constant for the cysteine amber 
suppressor tRNA suggest that anticodon mutations do not act independently. The 
reduction in kcat/Km with regard to a wild-type transcript for the amber 
suppressor is 31 00-fold, much less than the 5-6 orders of magnitude which would 
be predicted for a double mutant in which the individual mutations cause 
reductions of 3 ond two orders of magnitude. The Lltertiary and Llanti mutations 
also did not appear to act independently; in a double replacement mutant they 
caused a reduction in kcat/Km of 81-fold, rather than the 19-fold reduction 
predicted from their individual effects. On the other hand, mutations Llacc and 
~anti appear to act independently, the double mutant has a predicted specificity 
change of -1.4-fold, the observed value 1.0. 
The experiments also underscore the fundamental observation that in vivo 
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and in vitro experiments study different aspects of the tRNA/synthetase 
interaction. Surprisingly, amber suppressor tRNA acm2, which retains only 37% 
of its cysteine identity in vivo was found to be a better or equivalent substrate (in 
terms of kcat/Km) than other amber suppressor tRNAs which retain their identity 
in vivo (89% to 93% cysteine). One possible explanation for these anomalous 
results is that the cumulative effects of the three base pair changes in acm2 
improve recognition for the glutaminyl-tRNA synthetase (perhaps by repositioning 
the anticodon, which contains two recognition elements for GlnRS, C34 and U35, 
Jahn et al., 1991 ). A marginally improved affinity of acm2 for the glutaminyl-tRNA 
synthetase allows the GlnRS to successfully compete with the cysteinyl-tRNA 
synthetase for a poor substrate. Another possibility is that the cumulative effects 
of the mutations raised the Km of acm2 for the CysRS so that the glutaminyi-
RNA synthetase was able to compete successfully for this substrate. If the latter 
explanation is correct, it would seem to be an exception to the rule proposed by 
Hou and Schimmel (1989) that kcat produces the dominant effect in determining 
identity. Perhaps with tRNAs which are such poor substrates, other factors, such 
as Km, can be the dominant factor in determining identity in vivo. 
Whatever the reason for this anomaly, in vitro charging experiments do 
not include the effects of competition between synthetases, hence the data only 
reflects the recognition set, not the complete identity set Similarly, in vivo 
experiments study the complete identity set rather than the recognition set Only 
combined studies give a true picture of the interactions of an aminoacyl-tRNA 
synthetase and a tRNA. 
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Codon kcat Km kcatfKm Specificity 
recognized knmole min-1 mg proteln-1 (JlM) 
change 
(fold) 
CysGCA Cys 1,100 ±40 3.1± 0.4 350 a 
CysACA Cys 7.3 ± 0.6 38 ±5 0.19 -1800 
CysUCA Opal 4.6 ± 0.2 25 ±2 0.18 -1900 
CysCCA Trp 4.1 ± 0.4 30 ±5 0.14 -2500 
CysGAA Phe 950 ±40 3.3± 0.4 290 -1.2 
CysGUA Tyr 29 ± 2 28 ±2 1.1 -320 
CysGGA Ser 71 ± 7 25 ±4 2.8 -120 
CysGCU Ser 30 ± 5 10 ±3 2.9 -120 
CysGCG Arg 45 ± 2 18 ±2 2.5 -140 
CysGCC Gly 141 ± 6 16 ±1 8.6 -41 
Cys73A Cys 0.11± 0.02 4.0 ±1 .6 0.027 -13,000 
Cys73G Cys b b b b 
Cys73C Cys 0.76± 0.07 7.1 ±1 .5 0.11 -3200 
Table Ill: Kinetic parameters for anticodon and discriminator mutants. 
Specificity change is the level of decrease or increase in kcat1Km relative 
to a T7 transcribed tRNA&E'A See text for explanation of mutants. a) not 












































































































































































































































































































































Figure 1: Cloning and expression strategy for mutants of tRNACYs. A) RNA 
sequence of tRNACys from E. coli. (sequence from Sprinzl et al., 1991) B) 
Standard cassette produced from six oligonucleotides for cloning tRNAs. See text 
for details of the cloning. 
Figure 2: Michaelis-Menten plot for native and T7 transcribed tRNACYs. 
Figure 3: RNA sequence of T7 transcribed amber suppressor mutant tRNAs. The 
background sequence is the cysteine amber suppressor tRNA. The marked 
changes occur in the following mutant tRNAs: all changes, acm2; diamonds, 
acm5; circles, acm7; squares, acm8. 
Figure 4: Michaelis-Menten plot for amber suppressor tRNAs. Note that the data 
for acm8 is from a separate experiment, and its specificity change is calculated 
from a separate calculation of kcat/Km for CysGCA, a wild-type tRNACYs. 
Figure 5: Michaelis-Menten plot of CysGCA, the reference for the anticodon and 
discriminator mutants. 
Figure 6: Michaelis-Menten plot of wobble position (nucleotide 34) mutants of 
tRNACYS. 
Figure 7: Michaelis-Menten plot of CysGAA. 
Figure 8: Michaelis-Menten plot of CysGUA and CysGGA (nucleotide 35) 
mutants of tRNA Cys. 
94 
Figure 9: Michaelis-Menten plot of nucleotide 36 mutants of tRNACYs. 
Figure 10: Michaelis-Menten plot of discriminator (nucleotide 73) mutants of 
tRNACYS. 
Figure 11 : RNA sequence of T7 transcribed AS1 and AS2 tRNAs. See text for 
details about their design. A) AS1 B) AS2. 
Figure 12: RNA sequence of T7 transcribed tRNACys showing the breakpoints 
for the three structural regions used in the domain replacement experiments. 
Figure 13: Schematic diagram of the domain replacement mutants. Thick lines 
represent cysteine sequence, thin lines AS1 sequence. 
Figure 14: Michaelis-Menten plot of domain replacement mutants of tRNACYs. 
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Conclusions and Future Prospects 
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Abstract: 
The cysteinyl-tRNA synthetase uses the anticodon nucleotides, 
discriminator (nucleotide 73) and an element(s) within the tertiary domain of the 
molecule to recognize cognate tRNAs. The identity of the recognition element(s) 
in the tertiary domain remain to be established, but there are several likely 
candidates which bear future study, including the two dihydrouridine residues in 
the 0-loop, the A 13:A22 mismatch pair in the 0-stem, the unusual G15:G48 
Levitt pair, and possibly the variable pocket nucleotides {16, 20, 59, and 60). 
The three-dimensional structure of the tertiary domain might also be a 
recognition element. Although in vitro experiments cannot directly define the 
identity set, experiments with mutant glycine and phenylalanine tRNAs may be 
able to help show how these molecules are prevented from being misacylated 
with cysteine . Finally, the in vivo results obtained in this lab and others suggest 
that tRNA identity is overspecified and hence the notion of a simple set of 
recognition elements unique to an isoaccepting group (the "second genetic 
code") is incorrect. Fidelity is guaranteed not by a set of isoacceptor specific 
elements, but by the sum of many interactions between the synthetase and 
partially overlapping tRNA elements. 
1 1 1 
Identification of recognition elements In the tertiary domain: 
The tertiary domain of tRNACYs, consisting of the D stem and loop, the 
T'PC stem and loop, extra arm, and propeller twist nucleotides, contributes to 
recognition by the cysteinyl-tRNA synthetase. Replacing this region with 
sequences from a heterologous tRNA which varied in both a sequence and 
structure specific manner caused a reduction of 31-fold in the selectivity 
constant (kcat/Km) for aminoacylation by the cysteinyl-tRNA synthetase 
(CysRS). The nature of the element(s) which are recognized by the cysteinyl-
tRNA synthetase are unknown at this time. Unfortunately, the single isoacceptor 
of tRNACys prevents the use of comparison among cognate tRNAs to help 
identify recognition elements (see McClain and Nicholas Jr., 1987), but careful 
study of the sequence of the tRNA suggests several possible elements as 
targets for future study (see Figure 1 ). 
Unusual sequence elements within tRNACys are obvious candidates for 
recognition elements, and the most unusual element, of course, is the G15:G48 
Levitt pair found in no other E. coli tRNA. (Komine et al., 1990, Sprinzl et al. , 
1991 ). As indicated previously, G 15:G48 makes a perfectly reasonable tertiary 
pair in yeast tRNAPhe but reduces kcat/Km for the phenylalanyl-tRNA 
synthetase (FRS) fourfold and appears to subtly alter the three-dimensional 
structure of the tertiary domain (Sampson et al., 1990). A series of experiments 
in which the two "normal" Levitt pairs G15:C48 and A 15:U48 are inserted into 
tRNACys could provide interesting insight into the structural requirements of the 
tRNA, even if it turns out not to be the primary recognition element. 
The domain replacement experiments modified the sequence and 
structure of the D stem and loop, suggesting several other possible targets for 
future experiments. The D stem of tRNACys contains only three Watson-Crick 
base pairs, and an A 13:A22 mismatch pair (inferred from the U13:U23 
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mismatch pair in yeast tRNAAsp, Westhof et al., 1985), while the AS1 D stem 
was composed of four Watson-Crick pairs. The size and arrangement of the D 
loop also varies between the two tRNAs; in tRNACys it is seven nucleotides 
long and contains two dihydrouridine residues (U in the transcripts) both in the 
so called B region as compared to the single D residue in the a region of the 8 
nucleotide AS1 loop. In addition, the size of the a region is different between 
the two tRNAs, AS1 has a four nucleotide a region, tRNACys has a three 
nucleotide region. This implies that nucleotide16 or 17 of the D loop does not 
exist, and it shifts the location of the conserved G18G19 dinucleotide. A series 
of tRNAs with various D stem and loop elements could help determine if the 
recognition elements in the tertiary domain are in this structure. It should be 
noted that D stem and loop elements are involved in many of the tertiary 
interactions in tRNAs; mutations in this region may have to be paired with other 
changes in the variable loop to produce a functional tRNA (see below). 
Another interesting set of experiments would be to prepare tRNAs with 
the variants of the elements of the variable pocket, nucleotides 16, 17 (absent in 
tRNACYS, present in AS1 ), 20, 59, and 60 (Ladner et al., 1975). Variable pocket 
nucleotides are important in several other systems, especially yeast (Sampson 
et al., 1989) and E. coli (Peterson and Uhlenbeck, 1992) tRNAPhe and E. coli 
tRNALeu (G. Tocchini-Valentini, pers. comm.), making them good candidates for 
recognition elements in the E. coli cysteine system. There is only one common 
variable pocket nucleotide (C60) between tRNACys and AS1, so a series of 
tRNAs with mutations in the other three residues would be the logical place to 
begin . Since the two tRNAs have different numbers of variable pocket 
nucleotides, another interesting experiment could be performed with a tRNACys 
U17 insertion mutant. 
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It is also possible that the overall structure of the molecule is the 
important recognition element, or at least important in positioning other 
recognition elements. The crystal structures of yeast tRNAPhe (D4V5, Kim et al., 
197 4) and tRNAAsp (D3V 4, Westhof et al., 1985) suggest that D3V 4 tAN A Cys 
has a different three-dimensional structure than the D4V5 AS1 tRNA. 
Furthermore, Sampson et al., (1990) found that the G15:G48 Levitt pair affects 
the rate of lead cleavage in tRNAPhe suggesting that this too might contribute to 
a structural difference between AS1 tRNA and tRNACYs. A series of tRNAs 
which present the presumed AS1 tertiary interactions with or without cysteine 
sequence elements could also help ascertain the role of the tertiary domain in 
recognition by the cysteinyl-tRNA synthetase. The example of other systems 
suggest that structural clues have variable effects. Yeast aspartyl-tRNA 
synthetase is very tolerant of conformational variability, yeast phenylalanyl-
tRNA synthetase is much less so (Giege et al., 1990, Perret et al., 1992). 
In vitro methods of studying Identity: 
Although in vitro methods cannot answer general questions about tRNA 
identity, it may be possible to use these methods to determine how certain 
tRNAs are prevented from being misacylated in vivo. Specifically, in vitro 
experiments may allow us to determine the mechanisms that prevent E. coli 
tRNAs coding for phenylalanine and glycine from being charged with cysteine 
in vivo. 
Cysteine tRNAs with the GAA (Phe) and GCA (Cys) anticodons are 
equivalent substrates for the cysteinyl-tRNA synthetase, suggesting that some 
element in tRNAPhe must protect it from being aminoacylated with cysteine. The 
wild-type tRNAPhe discriminator is A73 which would be expected to reduce the 
catalytic efficiency of aminoacylation by the cysteinyl-tRNA synthetase by four 
orders of magnitude, effectively preventing misacylation. By testing the 
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aminoacylation kinetics of wild-type and U73 tRNAPhe molecules (Figure 2), it 
will be possible to if the discriminator is the sole defense against cysteine 
misacylation, or whether other negative elements in the tertiary domain help 
maintain Phe identity in vivo. 
There are three glycine specific isoacceptors in E. coli, with anticodons 
UCC (tRNAGiy1 ), GCC (tRNAGiy2), and CCC (tRNAGiy3). The different 
anticodon nucleotides would be expected to cause each tRNA to be 
aminoacylated by the cysteinyl-tRNA synthetase with different catalytic 
efficiencies. All else being equal tRNAGiy1 and tRNAGiy3 would be expected to 
be poor substrates because of the lack of the G34 wobble nucleotide. tRNAGiy2 
would be expected to be a better substrate (all else being equal) since the GCC 
anticodon was only reduced 41-fold in total catalytic efficiency in a tRNACys 
background compared to the wild-type GCA anticodon. All glycine tRNAs have 
aU at position 73, just like tRNACYS; the discriminator therefore cannot be used 
to prevent misacylation. Curiously, tRNAGiy1 is D3V4 like tRNACys while 
tRNAGiy2 is D4V5. It is intriguing to speculate that the tRNACYS-Iike tRNAGiy1 is 
prevented from mischarging with Cys primarily by the presence of U34 in the 
anticodon, while G34 containing tRNAGiy2 is prevented from mischarging by 
virtue of the structural differences inherent in its D4V5 tertiary domain. This is 
testable by aminoacylating mutants of tRNAGiy1 and tRNAGiy2 with both the 
UCC and GCC anticodons (Figure 3) . 
Final considerations on tRNA specificity: 
The results of studies on E. coli tRNAGin (Jahn et al., 1991, Normanly et 
al., 1990), tRNACys (this work, Normanly et al., 1986), and tRNAPhe (Peterson 
and Uhlenbeck, 1992, Normanly et al. , 1986) suggests that tRNAs are 
overspecified; mutants in which multiple recognition elements have been 
replaced reduce the total catalytic efficiency of the aminoacylation reaction but 
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do not change in vivo identity. In the examples above the anticodon is an 
important recognition element, yet amber suppressors made from these tRNAs 
retain their in vivo identity, despite the dramatic reductions in overall catalytic 
efficiency caused by the CUA anticodon. This suggests that a paradigm for 
discrimination must be devised which does not rely on recognition of a few 
unique elements (the so-called "second genetic code") but rather on 
competition between synthetases for substrates containing various numbers of 
somewhat overlapping recognition elements (for instance tRNACys and 
tRNAPhe both recognize A36 as part of their recognition sets : this work, 
Peterson and Uhlenbeck, 1992). Competition , and the balance between 
synthetase and tRNA concentrations ensure the fidelity of aminoacylation under 
this paradigm (general reference: Soli, 1990; specific experiments: Swanson et 
al., 1988, Sampson and Uhlenbeck, 1992, Sherman et al. , 1992). Although not 
as elegant as the simple model of the "second genetic code," it suggests that 
tRNA recognition and identity are dynamic processes, robust enough to tolerate 
the mutations which are the driving force in evolution. 
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Figure legends: 
Figure 1: RNA sequence of tRNACYs. Presumptive variable pocket nucleotides 
are circled. The a and B regions of the D loop are boxed and indicated. The 
two nucleotides which make the Levitt pair (G15 and G48) are indicated. 
Modified nucleotides are shown as the parent nucleotide. 
Figure 2: RNA sequences of E. coli and yeast tRNAPhe. Proposed mutations 
are shown as arrows away from the sequence. The mutation in base 3:70 of 
the E. coli tRNA is to improve transcription by the T7 RNA polymerase. 
Modified nucleotides are shown as the parent nucleotide. A) E. coli tRNAPhe 
B) Yeast tRNAPhe. 
Figure 3: RNA sequence of yeast E. coli tRNAGiy1 and tRNAGiy2 showing 
proposed mutations. Modified nucleotides are shown as the parent 
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Nucleotide Sequence of ORF2: An open reading frame upstream of 
the yeast tRNA ligase gene 
Portions of the work contained herein were presented in Komatsoulis, G. A., 
Westaway, S.K., & Abelson, J . N. (1987) Nucleic Acids Res. 15,9079. 
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Abstract: 
ORF2, an upstream open reading frame of the yeast tRNA ligase was 
sequenced and found to encode a putative protein product of 623 amino acids 
(molecular weight 71.3kD). Extensive computer analysis was conducted, but its 
function in vivo remains unknown. 
123 
Introduction: 
In baker's yeast, Saccharomyces cerevisiae, nine tRNA species contain 
small intervening sequences or introns which begin after nucleotide number 37, 
one base 3' of the anticodon (Ogden et al., 1984, numbering follows Sprinzl et 
al., 1991 ). These introns are removed in a multi-step reaction involving two 
enzymes: tRNA splicing endonuclease and tRNA ligase (Greer et al., 1983) as 
shown in Figure 1. The endonuclease has been purified and characterized by 
Rauhut et al. (1990) and the ligase was purified, characterized, and cloned by 
Phizicky et al. (1986). The tRNA ligase gene was sequenced by Westaway et al. 
(1988), who found several upstream open reading frames, including one 
(ORF2) with a transcription start only 125 base pairs from the start of tRNA 
ligase (but in the opposite direction). 
Knockout mutants of the tRNA ligase gene behaved unusually (E. 
Phizicky and S. K. Westaway, pers. comm.). The tRNA ligase reading frame was 
insufficient to complement such mutants; rescue of the lethal phenotype 
required tRNA ligase and several kilobases (kB) of upstream sequence. The 
ORF2 gene was subsequently found to be a single copy, essential gene; 
furthermore knockout mutations of ORF2 require the complete tRNA ligase-
ORF2 region for complementation (E. Phizicky & S. K. Westaway, pers. comm.) 
The apparent importance of this gene and its linkage to yeast tRNA ligase 
prompted the sequencing of the ORF2 gene. 
Results and Discussion: 
Sequencing of ORF2: 
Plasmid pSWS (Figure 2A, obtained from S. K. Westaway) was the 
source of ORF2 DNA for sequencing. Figure 28 shows the clones constructed 
for the sequencing project. Clones initiating with the number 8 were constructed 
in M13mp18 and those initiating with the number 9 were cloned in M13mp19. 
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Using these clones, an approximately 2.0 kB region was sequenced by the 
dideoxy chain termination method(Sanger et al., 1977), covering the remainder 
of ORF2 (Westaway et al., 1988 had sequenced the first 69 amino acids). The 
sequence is shown in Figure 3, including part of the tRNA ligase gene 
(Westaway et al., 1988). 
Analysis of the ORF2 gene and the hypothetical gene product: 
The gene and hypothetical gene product were analyzed using the 
University of Wisconsin Genetics Computer Group (GCG) package of sequence 
analysis programs (Genetics Computer Group, 1991 ). The ORF2 reading frame 
encodes a protein of 623 amino acids with a molecular mass of 71.3 kD. Figure 
4 shows its amino acid composition. The most striking feature is the large 
number (55) of lysine residues. Figure 5 shows the isoelectric graph for the 
putative ORF2 protein; its isoelectric point is 7.52. To help determine if the 
protein was membrane bound (one of the subunits of the tRNA splicing 
endonuclease is a membrane protein, Rauhut et al., 1990) a hydropathy plot 
was generated by the program PLOTSTRUCTURE (Figure 6), however no 
evidence of a transmembrane domain was seen. 
Comparisons of ORF2 with current protein databases were performed 
using several search algorithms, but no functional similarities were seen. Figure 
7 shows the result of a BLAST (Altschul et al., 1990) search. There is some 
similarity to a tomato protein with a leucine zipper, and a paramyosin gene from 
a fluke (one region from about amino acid 120-150 matches both proteins). 
Ultimately, however, the function of this protein is still unclear. 
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Figure 1: Mechanism of yeast tRNA splicing. After Greer et al. (1983). 
Figure 2: Cloning strategy. A) pSWS (S. K. Westaway, pers. comm.) was the 
source of ORF2 sequences. B) The Hpai-EcoRI fragment containing ORF2, 
showing M13mp18 and M13mp19 clones constructed for sequencing. See text 
for details. 
Figure 3 : Sequence of ORF2 and presumptive ORF2 protein product. The 
sequence includes some of the yeast tRNA ligase gene sequenced by 
Westaway et al. (1988). 
Figure 4: Composition and molecular weight of the hypothetical ORF2 protein 
product. 
Figure 5: lsoelectric graph of the hypothetical ORF2 product (from the GCG 
program ISOELECTRIC) 
Figure 6 : Output from GCG computer program PLOTSTRUCTURE (Wolf et al., 
1988) showing Kyte and Doolittle hydrophilicity, surface probability, flexibility , 
Jameson-Wolf antigenic index, Chou & Fasman and Garnier-Osguthorpe-
Robson secondary structure predictions, and predicted glycosylation sites. 


























.... _._ ____ 9121 and 8122----••~ 




1 TGGGCTAGGC ATCGCTTCTT CGTATGAATA CTTTTATGAT CACTAAAGTC AAAGTGTAGA 
61 TTTTCAAAGA AAGAAAGACT ATGCAAATGC GTAAAATTTG CTCGAAGCAA TTCTCAACAG 
121 AATGGAATGA ATTAGATGCT CTTCTGTATA CTTTCTTTGG GATAAACTCA TAGTGAAATT 
181 TTATCAATGG AAAAGTACGC GGCCGGCCCG CTGGAACATA AAGATAATTT ACTGAAACAG 
241 TGTGCTTAAA CGTATTTGAA AACCAAGGTG AATGTACCCT TAAAGTGCTG GCAGTGAATA 
301 GCAAAGGTCC ATTAAAGTGT TCTGGTTTTA TAATATCAAA AGCATTTATA GAA ATG CCC 
1 Met Pro 
360 GCT GAA ATT GAC ATT GAT GAA GCT GAC GTA TTA GTT TTA TCA CAG GAG 
3 Ala Glu Ile Asp Ile Asp Glu Ala Asp Val Leu Val Leu Ser Gln Glu 
408 TTA CAA AAG ACA AGT AAA CTC ACT TTC GAA ATC AAT AAA TCT TTG AAA 
19 Leu Gln Lys Thr Ser Lys Leu Thr Phe Glu Ile Asn Lys Ser Leu Lys 
456 AAA ATT GCA GCT ACA TCC AAT CAA TCC AGT CAA CTC TTC ACT CCT ATT 
35 Lys Ile Ala Ala Thr Ser Asn Gln Ser Ser Gln Leu Phe Thr Pro Ile 
504 CTT GCT AGA AAT AAT GTT TTA ACC ACA TTA CAA AGA AAT ATT GAA AGT 
51 Leu Ala Arg Asn As n Val Leu Thr Thr Leu Gln Arg Asn Ile Glu Ser 
552 ACA TTG AAT TCC GTT GCC TCA GTT AAG GAT CTA GCA AAC GAA GCT TCC 
67 Thr Leu Asn Ser Val Ala Ser Val Lys Asp Leu Ala Asn Glu Ala Ser 
600 AAG TAT GAG ATC ATT TTA CAA AAG GGT ATT AAT CAA GTC GGT TTA AAG 
83 Lys Tyr Glu Ile Ile Leu Gln Lys Gly Ile Asn Gln Val Gly Leu Lys 
648 CAA TAC ACC CAA GTA GTA CAT AAG CTA GAT GAT ATG TTG GAA GAC ATT 
99 Gln Tyr Thr Gln Val Val His Lys Leu Asp Asp Met Leu Glu Asp Ile 
696 CAG TCT GGA CAA GCC AAT CGA GAA GAA AAC TCA GAA TTC CAT GGG ATT 
115 Gln Ser Gly Gln Ala Asn Arg Glu Glu Asn Ser Glu Phe His Gly Ile 
744 TTA ACT CAC TTG GAA CAA TTG ATC AAA CGT AGC GAG GCT CAA CTA AGA 
131 Leu Thr Hi s Leu Glu Gln Leu Ile Lys Arg Ser Glu Ala Gln Leu Arg 
792 GTA TAT TTT ATT TCA ATT TTG AAC AGT ATT AAA CCG TTT GAT CCA CAA 
147 Val Tyr Phe Ile Ser Ile Leu Asn Ser Ile Lys Pro Phe Asp Pro Gln 
840 ATC AAT ATC ACC AAA AAG ATG CCA TTT CCA TAC TAC GAG GAC CAG CAG 
163 Ile Asn Ile Thr Lys Lys Met Pro Phe Pro Tyr Tyr Glu Asp Gln Gln 
888 TTA GGC GCT TTA TCG TGG ATT TTA GAT TAT TTT CAT GGA AAT TCA GAA 
179 Leu Gly Ala Leu Ser Trp Ile Leu Asp Tyr Phe His Gly Asn Ser Glu 
936 GGT TCT ATT ATA CAG GAC ATA CTC GTC GGT GAA AGG AGT AAA TTA ATC 
195 Gly Ser Ile Ile Gln Asp Ile Leu Val Gly Glu Arg Ser Lys Leu Ile 
984 CTC AAG TGC ATG GCA TTC CTT GAA CCT TTT GCC AAA GAA ATC AGC ACT1 
211 Leu Lys Cys Met Ala Phe Leu Glu Pro Phe Ala Lys Glu Ile Ser Thr 
1032 GCA AAA AAC GCC CCG TAT GAG AAG GGC AGT AGC GGG ATG AAC AGC TAC 
227 Ala Lys Asn Ala Pro Tyr Glu Lys Gly Ser Ser Gly Met Asn Ser Tyr 
1080 ACG GAG GCC TTA TTA GGC TTC ATC GCC AAT GAA AAA TCA CTA GTA GAC 
243 Thr Glu Ala Leu Leu Gly Phe Ile Ala Asn Glu Lys Ser Leu Val Asp 
130 
1128 GAC CTC TAC TCT CAA TAT ACA GAA AGT AAA CCC CAC GTC TTG TCA CAG 
259 Asp Leu Tyr Ser Gln Tyr Thr Glu Ser Lys Pro His Val Leu Ser Gln 
117 6 ATC TTG TCG CCT TTA ATT AGC GCA TAT GCT AAG CTT TTC GGT GCA AAT 
275 Ile Leu Ser Pro Leu Ile Ser Ala Tyr Ala Lys Leu Phe Gly Ala Asn 
1224 TTG AAA ATT GTA CGA AGC AAC CTC GAG AAC TTT GGA TTC TTT AGT TTT 
291 Leu Lys Ile Val Arg Ser Asn Leu Glu Asn Phe Gly Phe Phe Ser Phe 
1272 GAG CTA GTG GAA AGC ATA AAT GAT GTG AAA AAA TCT CTT CGA GGC AAG 
307 Glu Leu Val Glu Ser Ile Asn Asp Val Lys Lys Ser Leu Arg Gly Lys 
1320 GAA CTA CAA AAC TAT AAT TTA TTG CAA GAT TGT ACG CAA GAA GTA CGT 
323 Glu Leu Gln Asn Tyr Asn Leu Leu Gln Asp Cys Thr Gln Glu Val Arg 
1368 CAA GTA ACA CAG TCA TTA TTC AGA GAT GCC ATT GAT AGG ATT ATC AAA 
339 Gln Val Thr Gln Ser Leu Phe Arg Asp Ala Ile Asp Arg Ile Ile Lys 
1416 AAG GCA AAT TCT ATT TCT ACT ATT CCT TCC AAT AAT GGT GTC ACT GAA 
355 Lys Ala Asn Ser Ile Ser Thr Ile Pro Ser Asn Asn Gly Val Thr Gl 
1464 GCA ACT GTA GAT ACC ATG TCA AGA CTA AGA AAG TTC AGT GAG TAC AAA 
371 Ala Thr Val Asp Thr Met Ser Arg Leu Arg Lys Phe Ser Glu Tyr Lys 
1512 AAC GGA TGT TTA GGC GCC ATG GAC AAT ATC ACA CGT GAA AAT TGG TTA 
387 Asn Gly Cys Leu Gly Ala Met Asp Asn Ile Thr Arg Glu Asn Trp Leu 
1560 CCA TCC AAT TAT AAG GAG AAA GAA TAC ACT TTG CAA AAC GAG GCT TTA 
403 Pro Ser Asn Tyr Lys Glu Lys Glu Tyr Thr Leu Gln Asn Glu Ala Leu 
1608 AAT TGG GAA GAT CAT AAT GTA TTA CTA TCA TGT TTT ATA AGT GAT TGC 
419 Asn Trp Glu Asp His Asn Val Leu Leu Ser Cys Phe Ile Ser Asp Cys 
1656 ATA GAC ACT TTG GCA GTT AAT CTT GAG AGA AAG GCA CAA ATA GCA CTG 
435 Ile Asp Thr Leu Ala Val Asn Leu Glu Arg Lys Ala Gln Ile Ala Leu 
1704 ATG CCT AAC CAA GAG CCA GAT GTG GCT AAT CCT AAT AGC TCT AAA AAT 
451 Met Pro Asn Gln Glu Pro Asp Val Ala Asn Pro Asn Ser Ser Lys Asn 
17 52 AAG CAC AAG CAA CGT ATT GGA TTC TTC ATT TTA ATG AAC CTG ACG CTT 
467 Lys His Lys Gln Arg Ile Gly Phe Phe Ile Leu Met Asn Leu Thr Leu 
1800 GTT GAG CAG ATC GTG GAA AAG TCA GAA TTA AAC TTA ATG TTA GCT GGA 
483 Val Glu Gln Ile Val Glu Lys Ser Glu Leu Asn Leu Met Leu Ala Gly 
1848 GAA GGT CAC TCC AGA TTG GAA CGG CTG AAG AAA CGT TAT ATT AGT TAT 
499 Glu Gly His Ser Arg Leu Glu Arg Leu Lys Lys Arg Tyr Ile Ser Tyr 
1896 ATG GTA TCA GAT TGG AGA GAT TTA ACT GCA AAT TTG ATG GAT TCT GTG 
515 Met Val Ser Asp Trp Arg Asp Leu Thr Ala Asn Leu Met Asp Ser Val 
1944 TTT ATT GAT AGT AGC GGG AAG AAG TCA AAA GAC AAA GAA CAA ATA AAG 
531 Phe Ile Asp Ser Ser Gly Lys Lys Ser Lys Asp Lys Glu Gln Ile Lys 
1992 GAG AAA TTT AGA AAA TTC AAT GAA GGA TTC GAA GAT TTA GTA TCA AAA 
547 Glu Lys Phe Arg Lys Phe Asn Glu Gly Phe Glu Asp Leu Val Ser Lys 
131 
2040 ACA AAA CAG TAT AAG CTT TCA GAT CCA TCA TTG AAA GTA ACT TTG AAG 
563 Thr Lys Gln Tyr Lys Leu Ser Asp Pro Ser Leu Lys Val Thr Leu Lys 
2088 TCA GAA ATA ATA TCG TTG GTT ATG CCC ATG TAT GAA AGA TTC TAC AGT 
579 Ser Glu Ile Ile Ser Leu Val Met Pro Met Tyr Glu Arg Phe Tyr Ser 
2136 AGA TAT AAA GAC TCT TTC AAG AAT CCT AGA AAG CAT ATC AAA TAT ACC 
595 Arg Tyr Lys Asp Ser Phe Lys Asn Pro Arg Lys His Ile Lys Tyr Thr 
2184 CCT GAC GAA CTA ACT ACT GTT CTT AAC CAA TTA GTG AGA TAG ATTGCGAACA 
611 Pro Asp Glu Leu Thr Thr Val Leu Asn Gln Leu Val Arg 623 
2236 TCACTTTTCA AAAAGCAAAA TTAAAGAAAA GAACGTACCA TAAACAGATA TAAACATATA 
2296 TATGTATAAC AATTAGAGTT TCTAATATTT TATGTTTGCT CTGGACGCCA GATGTAAGAA 
2356 CAGGAAGGGA TGACGTAGGA ACCTTGTGCT AGACTAAAGG GTACTCTCAT TTATACTTTG 
2416 TAATCCAGAT TCATTATCTA ACGTATTAAT CAGTACTTTC TCGGGTGAAG AAAGTCTTGA 
2476 AATAAATCTT TCCTCGGAAT CAGAATTC 2503 
132 
Figure 4 
PEPSTATS of: Orf2.Pep check: 3448 from: 1 to: 623 
Continuous From: 1 To: 623 Length: 623 
Summary for whole sequence: 
Molecular weight = 71292 . 82 Residues = 623 
Average Residue Weight = 114.435 Charge = +9 
Residue Number Mole Percent 
A = Ala 31 4.976 
c = Cys 5 0.803 
D = Asp 32 5.136 
E = Glu 48 7.705 
F = Phe 26 4.173 
G = Gly 22 3.531 
H = His 9 1. 445 
I = Ile 46 7.384 
K = Lys 55 8.828 
L = Leu 71 11.396 
M = Met 14 2.247 
N = Asn 43 6.902 
p = Pro 19 3.050 
Q = Gln 32 5 . 136 
R = Arg 25 4.013 
s = Ser 59 9.470 
T = Thr 29 4.655 
v = Val 31 4.976 
w = Trp 4 0.642 
y = Tyr 22 3.531 
Small (A+G) 53 8 . 507 
Hydroxyl (S+T) 88 14.125 
Acidic (D+E) 80 12.841 
Acid/Amide (D+E+N+Q) 155 24.880 
Basic (H+K+R) 89 14 . 286 
Charged (D+E+H+K+R) 169 27 . 127 
Small hphob (I+L+M+V) 162 26 . 003 















































































































































































































































































































































































































































































































































































































Database: Non-redundant SwissProt+PIR+GenPept+GPUpdate, 4:35 AM EST Jan 
10,1993 
84,347 sequences; 23,751,181 total residues. 





Sequences producing High-scoring Segment Pairs: Score P(N) N 
SP:YTRL_YEAST HYPOTHETICAL 71.3 KD PROTEIN IN TRNA LIGAS.3237 0.0 1 
PIR:S21495 *Hypothetical protein - Tomato 51 0.045 4 
GP:TOMLEUZIP_ 1 L.esculentum mRNA for protein with leucine . .. Sl 0.046 4 
SP:MYSP_SCHMA PARAMYOSIN. >GP: SCMPMY_l Schistosoma manso .. 50 0.29 2 
PIR:A25993 Paramyosin - Fluke (Schistosoma mansoni) so 0.29 2 
GP:SCMPMYAl - 1 S.mansoni paramyosin mRNA, complete cds. 50 0.49 2 
>SP:YTRL_YEAST HYPOTHETICAL 71.3 KD PROTEIN IN TRNA LIGASE 3'REGION. 
>PIR:A27300 Hypothetical protein, 71K - Yeast (Saccharomyces 
cerevisiae) >GP:YSCORF2_2 Yeast DNA for ORF2 upstream of 
tRNA 
ligase gene. [Saccharomyces cerevisiae) 
Length = 623 
Score= 3237 (1565.3 bits), Expect= 0.0, P = 0.0 






















































601 KNPRKHIKYTPDELTTVLNQLVR 623 
KNPRKHIKYTPDELTTVLNQLVR 
601 KNPRKHIKYTPDELTTVLNQLVR 623 
>PIR:S21495 *Hypothetical protein - Tomato 
Length = 631 
137 
Score= 51 (24.7 bits), Expect= 98., P = 1.0 
Identities= 16/60 (26%), Positives= 29/60 (48%) 
Query:IKEKFRKFNEGFEDLVSKTKQYKLSDPSLKVTLKSEIISLVMPMYERFYSRYKDSFKNPR 604 
+KEK + FN FE++ + D LK L+ + + + P Y F +R + ++R 
Sbjct:LKEKLKLFNSYFEEICKTQSTWIIFDEQLKEELRISVAGALSPAYRNFIGRLQSNNDSSR 599 
Score= 46 (22.2 bits), Expect= 5.3e+02, Poisson P(2) = 0.97 
Identities= 7/25 (28%), Positives= 19/25 (76%) 
Query: 
Sbjct: 
597 KDSFKNPRKHIKYTPDELTTVLNQL 621 
+DS ++ +HIK++ ++L + +++L 
595 NDSSRHTERHIKFSVEDLEARISEL 619 
Score= 41 (19.8 bits), Expect= 2.8e+03, Poisson P(4) = 0.045 
Identities= 9/20 (45%), Positives= 11/20 (55%) 
Query: 
Sbjct: 
128 HGILTHLEQLIKRSEAQLRV 147 
+GI LE LI+R A V 
365 RGIFMELENLIRRDPAKTPV 384 
Score= 41 (19.8 bits), Expect= 2.8e+03, Poisson P(4) 
Identities= 9/25 (36%), Positives= 15/25 (60%) 
Query: 
Sbjct: 
475 FILMNLTLVEQIVEKSELNLMLAGE 499 
F++ N + Q V SEL L+L+ + 
471 FMMNNERYIVQKVKDSELGLLLGDD 495 
0.045 
>GP:TOMLEUZIP_l L.esculentum mRNA for protein with leucine zipper. 
[Lycopersicon esculentum) 
Length = 632 
Score= 51 (24.7 bits), Expect= 98., P = 1.0 
Identities= 16/60 (26%), Positives= 29/60 (48%) 
Query:IKEKFRKFNEGFEDLVSKTKQYKLSDPSLKVTLKSEIISLVMPMYERFYSRYKDSFKNPR 604 
+KEK + FN FE++ + D LK L+ + + + P Y F +R + ++R 
Sbjct:LKEKLKLFNSYFEEICKTQSTWIIFDEQLKEELRISVAGALSPAYRNFIGRLQSNNDSSR 599 
Score= 46 (22.2 bits), Expect= 5.3e+02, Poisson P(2) = 0.97 
Identities= 7/25 (28%), Positives= 19/25 (76%) 
Query: 
Sbjct: 
597 KDSFKNPRKHIKYTPDELTTVLNQL 621 
+DS ++ +HIK++ ++L + +++L 
595 NDSSRHTERHIKFSVEDLEARISEL 619 
Score 41 (19.8 bits), Expect= 2.8e+03, Poisson P(4) = 0.046 
Identities= 9/20 (45%), Positives= 11/20 (55%) 
Query: 
Sbjct: 
128 HGILTHLEQLIKRSEAQLRV 147 
+GI LE LI+R A V 
365 RGIFMELENLIRRDPAKTPV 384 
138 
Score= 41 (19.8 bits), Expect= 2.8e+03, Poisson P(4) = 0.046 
Identities= 9/2S (36%), Positives= 1S/2S (60%) 
Query: 
Sbjct: 
47S FILMNLTLVEQIVEKSELNLMLAGE 499 
F++ N + Q V SEL L+L+ + 
471 FMMNNERYIVQKVKDSELGLLLGDD 49S 
>SP:MYSP_SCHMA PARAMYOSIN. >GP:SCMPMY_1 Schistosoma rnansoni (blood 
fluke) 
pararnyosin rnRNA, partial cds. [Schi stosoma mansoni] 
Length = 439 
Score= SO (24.2 bits) , Expect= 1.4e+02, P = 1.0 
Identities= 13/43 (30%), Positives= 25/43 (58%) 
Query: 23 SKLTFEINKSLKKIAATSNQSSQLFTPILARNNVLTTLQRNIE 65 
+KLT EI+ I + S ++S+L A +++ + LQR ++ 
Sbjct: 33 TKLTLEIKDLQSEIESLSLENSELIRRAKAAESLASDLQRRVD 75 
Score= 49 (23.7 bits), Expect= 1.9e+02, Poisson P(2) = 0.29 
Identities= 9/24 (37%), Positives= 18/24 (7S%) 
Query: 
Sbjct: 
122 EENSEFHGILTHLEQLIKRSEAQL 14S 
+E E ++ L +LE+L K++E++L 
298 NEIEEIRSTLENLERLRKHAETEL 321 
>PIR:A25993 Paramyosin - Fluke (Schistosoma mansoni) (fragment) 
Length = 439 
Score= 50 (24 . 2 bits), Expect= 1.4e+02, P = 1.0 
Identities= 13/43 (30%), Positives= 25/43 (58%) 
Query: 23 SKLTFEINKSLKKIAATSNQSSQLFTPILARNNVLTTLQRNIE 6S 
+KLT EI+ I + S ++S+L A +++ + LQR ++ 
Sbjct: 33 TKLTLEIKDLQSEIESLSLENSELIRRAKAAESLASDLQRRVD 75 
Score= 49 (23.7 bits), Expect= 1.9e+02, Poisson P(2) = 0.29 
Identities= 9/24 (37%), Positives= 18/24 (7S%) 
Query: 
Sbjct: 
122 EENSEFHGILTHLEQLIKRSEAQL 145 
+E E ++ L +LE+L K++E++L 
298 NEIEEIRSTLENLERLRKHAETEL 321 
>GP:SCMPMYA1 1 S . mansoni paramyosin mRNA, complete cds. [Schistosoma 
mansoni ] 
Length = 866 
Score= SO (24.2 bits), Expect= 1 . 4e+02, P = 1.0 
Identities= 13/43 (30%), Positives= 2S/43 (58%) 
Query: 23 SKLTFEINKSLKKIAATSNQSSQLFTPILARNNVLTTLQRNIE 65 
+KLT EI+ I + S ++S+L A +++ + LQR ++ 
Sbjct: 335 TKLTLEIKDLQSEIESLSLENSELIRRAKAAESLASDLQRRVD 377 
Score= 49 (23.7 bits), Expect= 1.9e+02, Poisson P(2) = 0.49 
139 
Identities= 9/24 (37%), Positives= 18/24 (75%) 
Query: 
Sbjct: 
122 EENSEFHGILTHLEQLIKRSEAQL 145 
+E E ++ L +LE+L K++E++L 
600 NEIEEIRSTLENLERLRKHAETEL 623 
Parameters: 
E = 1. 7 1 s = 63 (30. 5 bits), E2 = 0.090, S2 
w = 3, T = 12 (5.8 bits), X = 21 (10 . 2 bits) 
M = PAM120 
H = 0, v = 500, B = 250 
Statistics: 
36 
Lambda = 0.335 nats/unit score, Larnbda/ln2 = 0.484 bits/unit score 
K = 0.182, H = 0.837 bits /pos ition 
Expected/Observed high score = 64 (30.9 bits) I 3237 (1565.3 bits) 
* of residues in query: 623 
*of neighborhood words in query: 10,777 
* of exact words scoring below T: 20 
Database: Non-redundant SwissProt+PIR+GenPept+GPUpdate, 4:35 AM EST 












residues in database: 23,751,181 
word hits against database: 20,985,520 
failed hit extensions: 17,521,674 
excluded hits: 3,463,612 
successful extensions: 234 
overlapping HSPs discarded: 219 
HSPs reportable: 15 
sequences in database: 84,347 
database sequences with at least one HSP : 6 
states in DFA: 549 (54 KB) 
Total size of DFA : 163 KB (176 KB) 
Time to generate n eighborhood : 0 .12u 0.02s 0.14t 
No. of processors used: 8 
Time to search database: 30.4lu 0.64s 31.05t 
Total cpu time: 30.60u 0.71s 31.31t 
<END 
